<SEC-DOCUMENT>0000950103-25-014291.txt : 20251104
<SEC-HEADER>0000950103-25-014291.hdr.sgml : 20251104
<ACCEPTANCE-DATETIME>20251104172443
ACCESSION NUMBER:		0000950103-25-014291
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20251104
DATE AS OF CHANGE:		20251104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251450838

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251450839

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp236919_424b2-us2525369d.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 57%; font-size: 10pt; color: #888888"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD>
    <TD STYLE="width: 43%">
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">October 31, 2025</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Medium-Term Senior Notes, Series
    N</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Pricing Supplement No. 2025-USNCH29179</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Filed Pursuant to Rule 424(b)(2)</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Registration Statement Nos. 333-270327
    and 333-270327-01</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P></TD></TR>
  </TABLE>
<P STYLE="color: #59AE43; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Autocallable Equity Linked Securities Linked to the
Worst Performing of the FTSE MIB Index, the Nikkei 225 Index, the Russell 2000<SUP>&reg; </SUP>Index and the EURO STOXX<SUP>&reg;</SUP>
Banks Index Due April 29, 2027</P>

<P STYLE="color: #59AE43; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 4.5pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>The securities offered by this pricing supplement are unsecured debt securities issued by Citigroup Global Markets Holdings Inc. and
guaranteed by Citigroup Inc. The securities offer periodic coupon payments at an annualized rate that is generally higher than the yield
on our conventional debt securities of the same maturity. In exchange for this higher yield, you must be willing to accept the risks that
(i) the securities may be automatically called for redemption prior to maturity in the circumstances described below and (ii) if the securities
are not automatically redeemed prior to maturity and a downside event (as described below) occurs, you may receive significantly less
than the stated principal amount of your securities, and possibly nothing, at maturity. Each of these risks will depend solely on the
performance of the <B>worst performing</B> of the underlyings specified below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 4.5pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>You will be subject to risks associated with <U>each</U> of the underlyings and will be negatively affected by adverse movements in
<U>any one</U> of the underlyings. Although you will have downside exposure to the worst performing underlying, you will not receive dividends
with respect to any underlying or participate in any appreciation of any underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 4.5pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>Investors in the securities must be willing to accept (i) an investment that may have limited or no liquidity and (ii) the risk of
not receiving any payments due under the securities if we and Citigroup Inc. default on our obligations. <B>All payments on the securities
are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD STYLE="width: 17%; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>KEY TERMS</B></FONT></TD>
    <TD STYLE="width: 83%; font-size: 12pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issuer:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Guarantee:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 17%"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlyings:</TD>
    <TD STYLE="width: 38%; border: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 22%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Initial underlying value*</B></FONT></TD>
    <TD STYLE="width: 23%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt; color: #59AE40"><B>Downside threshold value**</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">FTSE MIB Index</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">43,122.19</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">30,918.610</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">Nikkei 225 Index</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">50,453.64</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">36,175.260</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">Russell 2000<SUP>&reg; </SUP>Index</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">2,506.650</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">1,797.268</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">EURO STOXX<SUP>&reg;</SUP> Banks Index</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">229.74</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">164.724</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* For the Russell 2000<SUP>&reg; </SUP>Index, its closing value on the
    strike date; for each of the FTSE MIB Index, the Nikkei 225 Index and the EURO STOXX<SUP>&reg;</SUP> Banks Index, its opening value on
    October 29, 2025</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">** For each underlying, 71.70% of its initial underlying value</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD STYLE="width: 17%; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Stated principal amount: </B></FONT></TD>
    <TD STYLE="width: 83%; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: Black">$1,000 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Strike date:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">October 28, 2025. <I>The initial underlying value for the Russell 2000<SUP>&reg; </SUP>Index is its closing value on the strike date, and the initial underlying value for each of the FTSE MIB Index, the Nikkei 225 Index and the EURO STOXX<SUP>&reg;</SUP> Banks Index is its opening value on October 29, 2025.</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Pricing date:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">October 31, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issue date:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">November 5, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Valuation date:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">April 22, 2027, subject to postponement if such date is not a scheduled trading day or certain market disruption events occur</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Maturity date: </B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Unless earlier redeemed, April 29, 2027</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Coupon payment dates:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">The 29th day of each January, April, July and October, beginning in January 2026 provided that the April 2027 coupon payment date will be the maturity date. If any coupon payment date is not a business day, the payment to be made on that coupon payment date will be made on the next succeeding business day with the same force and effect as if made on that coupon payment date. No interest will accrue as a result of any delayed payment.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Coupon payments:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">On each coupon payment date, unless previously redeemed, the securities will pay a coupon equal to 2.15% of the stated principal amount of the securities (equivalent to a coupon rate of 8.60% per annum).</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Payment at maturity:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the securities are not automatically redeemed prior to maturity,
    you will receive at maturity, for each security you then hold, the final coupon payment <I>plus</I>:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 16.75pt; text-indent: -0.25in"><FONT STYLE="font-size: 10pt">&squarf;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT></FONT>If a downside event <U>does not</U> occur: $1,000</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 16.75pt; text-indent: -0.25in"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 16.75pt; text-indent: -0.25in"><FONT STYLE="font-size: 10pt">&squarf;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT></FONT>If a downside event occurs: $1,000 + ($1,000 &times; the underlying return of the worst performing underlying on the valuation
    date)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 16.75pt; text-indent: -0.25in"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the securities have not been automatically redeemed prior to maturity
    and a downside event occurs, you will receive less than 71.70% of the stated principal amount of your securities, and possibly nothing,
    at maturity. You should not invest in the securities unless you are willing and able to bear the risk of losing a significant portion,
    and up to all, of your investment.</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Downside event:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">A downside event will occur if the final underlying value of the worst performing underlying on the valuation date is less than its downside threshold value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Listing:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">The securities will not be listed on any securities exchange</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriter:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Inc. (&ldquo;CGMI&rdquo;), an affiliate of the issuer, acting as principal</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD STYLE="width: 22%"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriting fee and issue price:</B></FONT></TD>
    <TD STYLE="width: 26%; text-align: center; font-size: 10pt; color: #59AE43"><B>Issue price<SUP>(1)</SUP></B></TD>
    <TD STYLE="width: 23%; text-align: center; font-size: 10pt; color: #59AE43"><B>Underwriting fee<SUP>(2)</SUP></B></TD>
    <TD STYLE="width: 29%; text-align: center; font-size: 10pt; color: #59AE43"><B>Proceeds to issuer</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Per security:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,000</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$28.50</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$971.50</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Total:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$400,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$11,400.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$388,600.00</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 4.5pt; text-align: right; text-indent: 0in"><I>(Key Terms continued
on next page)</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 4.5pt; text-align: right; text-indent: 0in"></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(1) On the date of this pricing supplement, the estimated value of the
securities is $960.10 per security, which is less than the issue price. The estimated value of the securities is based on CGMI&rsquo;s
proprietary pricing models and our internal funding rate. It is not an indication of actual profit to CGMI or other of our affiliates,
nor is it an indication of the price, if any, at which CGMI or any other person may be willing to buy the securities from you at any time
after issuance. See &ldquo;Valuation of the Securities&rdquo; in this pricing supplement.</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(2) For more information on the distribution of the securities, see
&ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement. In addition to the underwriting fee, CGMI and its affiliates
may profit from hedging activity related to this offering, even if the value of the securities declines. See &ldquo;Use of Proceeds and
Hedging&rdquo; in the accompanying prospectus.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investing in the securities involves risks not associated with an
investment in conventional debt securities. See &ldquo;Summary Risk Factors&rdquo; beginning on page PS-5.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of the securities or determined that this pricing supplement and the accompanying
product supplement, underlying supplement, prospectus supplement and prospectus are truthful or complete. Any representation to the contrary
is a criminal offense. <I>You should read this pricing supplement together with the accompanying product supplement, underlying supplement,
prospectus supplement and prospectus, which can be accessed via the hyperlinks below:</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003818/dp190217_424b2-ea0210.htm" STYLE="color: rgb(89,174,67)"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Product Supplement No. EA-02-10 dated March 7, 2023</B></FONT></A><FONT STYLE="font-size: 10pt; color: #59AE43">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm" STYLE="color: rgb(89,174,67)"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying Supplement No. 11 dated March 7, 2023</B></FONT></A><FONT STYLE="font-size: 10pt; color: #59AE43"><BR>
</FONT><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000119312523063080/d470905d424b2.htm" STYLE="color: rgb(89,174,67)"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Prospectus Supplement and Prospectus each dated March 7, 2023</B></FONT></A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The securities are not bank deposits and are
not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of,
or guaranteed by, a bank.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt; color: white"><B>KEY TERMS (continued)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Automatic early redemption:</B></FONT></TD>
    <TD STYLE="width: 75%"><FONT STYLE="font-size: 10pt">If, on any potential autocall date, the closing value of the worst performing underlying on that potential autocall date is greater than or equal to its initial underlying value, each security you then hold will be automatically called on that potential autocall date for redemption on the immediately following coupon payment date for an amount in cash equal to $1,000 <I>plus</I> the related coupon payment. <B>The automatic early redemption feature may significantly limit your potential return on the securities.&nbsp;&nbsp;If the worst performing underlying performs in a way that would otherwise be favorable, the securities are likely to be automatically called for redemption prior to maturity, cutting short your opportunity to receive coupon payments. The securities may be automatically called for redemption as early as the first potential autocall date specified below.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Potential autocall dates:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">April 22, 2026, July 22, 2026, October 22, 2026 and January 22, 2027, each subject to postponement as if such date were the valuation date as described in the accompanying product supplement.&nbsp;&nbsp;If a scheduled potential autocall date is postponed by one or more business days, the immediately following coupon payment date will be postponed by an equal number of business days.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Final underlying value:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For each underlying, its closing value on the valuation date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Worst performing underlying:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For any date, the underlying with the lowest underlying return on that date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying return:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For each underlying on any date, (i) its closing value on that date <I>minus</I> its initial underlying value, <I>divided by</I> (ii) its initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">17331BUP2 / US17331BUP20 </FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><FONT STYLE="font-weight: normal">Additional Information</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The terms of the securities are set forth in the accompanying product
supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement. The accompanying product supplement, prospectus
supplement and prospectus contain important disclosures that are not repeated in this pricing supplement. For example, certain events
may occur that could affect your payment at maturity. These events and their consequences are described in the accompanying product supplement
in the sections &ldquo;Description of the Securities&mdash;Consequences of a Market Disruption Event; Postponement of a Valuation Date&rdquo;
and &ldquo;Description of the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying Index&mdash;Discontinuance
or Material Modification of an Underlying Index,&rdquo; and not in this pricing supplement. The accompanying underlying supplement contains
important disclosures regarding the Nikkei 225 Index, the Russell 2000<SUP>&reg; </SUP>Index and the EURO STOXX<SUP>&reg;</SUP> Banks
Index that are not repeated in this pricing supplement. It is important that you read the accompanying product supplement, underlying
supplement, prospectus supplement and prospectus together with this pricing supplement in connection with your investment in the securities.
Certain terms used but not defined in this pricing supplement are defined in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><FONT STYLE="font-weight: normal">Hypothetical Examples
of the Payment at Maturity on the Securities</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The table below indicates what your payment at maturity would be for
various hypothetical underlying returns of the worst performing underlying on the valuation date, assuming the securities are not automatically
redeemed prior to maturity. Your actual payment at maturity (if the securities are not automatically redeemed prior to maturity) will
depend on the actual final underlying value of the worst performing underlying on the valuation date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 85%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: #EAF3E0">
    <TD STYLE="width: 50%; padding-left: 5.1pt; text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt; color: #59AE40"><B>Hypothetical Underlying Return of Worst Performing Underlying on the Valuation Date</B></FONT></TD>
    <TD STYLE="width: 50%; padding-left: 4.85pt; text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt; color: #59AE40"><B>Hypothetical Payment at Maturity<SUP>(1)</SUP></B></FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">50.00%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,021.50</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">20.00%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,021.50</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">10.00%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,021.50</FONT></TD></TR>
  <TR STYLE="background-color: #EAF3E0">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,021.50</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">-10.00%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,021.50</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">-20.00%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,021.50</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">-28.30%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,021.50</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">-28.31%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$738.40</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">-30.00%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$721.50</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">-40.00%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$621.50</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">-50.00%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$521.50</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">-60.00%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$421.50</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">-70.00%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$321.50</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">-80.00%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$221.50</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">-90.00%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$121.50</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">-100.00%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$21.50</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>(1)</SUP> Includes final coupon payment. Each security has a stated
principal amount of $1,000.00.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below illustrate how to determine the payment at maturity
on the securities, assuming the securities are not automatically redeemed prior to maturity. You should understand that the term of the
securities, and your opportunity to receive the coupon payments on the securities, may be limited by the automatic early redemption feature
of the securities, which is not reflected in the examples below. The outcomes illustrated below are not exhaustive, and your actual payment
at maturity on the securities (if the securities are not earlier automatically redeemed) may differ from any example illustrated below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below are based on the following hypothetical values and
do not reflect the actual initial underlying values or downside threshold values of the underlyings. For the actual initial underlying
value and downside threshold value of each underlying, see the cover page of this pricing supplement. We have used these hypothetical
values, rather than the actual values, to simplify the calculations and aid understanding of how the securities work. However, you should
understand that the actual payments on the securities will be calculated based on the actual initial underlying value and downside threshold
value of each underlying, and not the hypothetical values indicated below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; border: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 32%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Hypothetical initial underlying value</B></FONT></TD>
    <TD STYLE="width: 35%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Hypothetical downside threshold value</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">FTSE MIB Index</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">100</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; padding-left: 3.8pt; text-align: center"><FONT STYLE="font-size: 10pt">71.70 (71.70% of its hypothetical initial underlying value)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">Nikkei 225 Index</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">100</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; padding-left: 3.8pt; text-align: center"><FONT STYLE="font-size: 10pt">71.70 (71.70% of its hypothetical initial underlying value)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">Russell 2000<SUP>&reg; </SUP>Index</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">100</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; padding-left: 3.8pt; text-align: center"><FONT STYLE="font-size: 10pt">71.70 (71.70% of its hypothetical initial underlying value)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">EURO STOXX<SUP>&reg;</SUP> Banks Index</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">100</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; padding-left: 3.8pt; text-align: center"><FONT STYLE="font-size: 10pt">71.70 (71.70% of its hypothetical initial underlying value)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The hypothetical examples below illustrate the calculation of the payment
at maturity on the securities, assuming that the securities have not been earlier automatically redeemed and that the final underlying
values of the underlyings are as indicated below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 10%; border: #59AE43 1pt solid; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 21%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt; background-color: white"><B>Hypothetical final underlying value of </B></FONT><B><FONT STYLE="font-size: 10pt">FTSE MIB Index </FONT></B></TD>
    <TD STYLE="width: 18%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt; background-color: white"><B>Hypothetical final underlying value of </B></FONT><B><FONT STYLE="font-size: 10pt">Nikkei 225 Index </FONT></B></TD>
    <TD STYLE="width: 18%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt; background-color: white"><B>Hypothetical final underlying value of </B></FONT><B><FONT STYLE="font-size: 10pt">Russell 2000<SUP>&reg; </SUP>Index </FONT></B></TD>
    <TD STYLE="width: 18%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt; background-color: white"><B>Hypothetical final underlying value of </B></FONT><B><FONT STYLE="font-size: 10pt">EURO STOXX<SUP>&reg;</SUP> Banks Index</FONT></B></TD>
    <TD STYLE="width: 15%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt; background-color: white"><B>Hypothetical payment at maturity per $1,000 security</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Example 1</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">150</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">130</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">120</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="vertical-align: top; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">140</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt"><B>$1,021.50 </B></FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 10%; border: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"></TD>
    <TD STYLE="width: 21%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(underlying return =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(150 &ndash; 100) / 100 = 50%)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD>
    <TD STYLE="width: 18%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(underlying return =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(130 &ndash; 100) / 100 = 30%)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD>
    <TD STYLE="width: 18%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(underlying return =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(120 &ndash; 100) / 100 = 20%)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD>
    <TD STYLE="width: 18%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(underlying return =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(140 &ndash; 100) / 100 = 40%)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD>
    <TD STYLE="width: 15%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Example 2</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">105</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(underlying return =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(105 &ndash; 100) / 100 = 5%)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">140</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(underlying return =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(140 &ndash; 100) / 100 = 40%)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">90</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(underlying return =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(90 &ndash; 100) / 100 = -10%)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">30</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(underlying return =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(30 &ndash; 100) / 100 = -70%)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt"><B>$321.50</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><B>Example 1: </B>In this example, the Russell 2000<SUP>&reg;
</SUP>Index has the lowest underlying return and, therefore, is the worst performing underlying on the valuation date. In this scenario,
the final underlying value of the worst performing underlying on the valuation date is greater than its downside threshold value and,
as a result, a downside event <U>does not</U> occur. Accordingly, at maturity, you would receive the $1,000 stated principal amount of
the securities <I>plus</I> the final coupon payment. You would not participate in the appreciation of any of the underlyings.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><B>Example 2: </B>In this example, the EURO STOXX<SUP>&reg;</SUP>
Banks Index has the lowest underlying return and, therefore, is the worst performing underlying on the valuation date. In this scenario,
the final underlying value of the worst performing underlying on the valuation date is less than its downside threshold value and, as
a result, a downside event occurs. Accordingly, at maturity, you would receive a payment per security calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">Payment at maturity = $1,000 + ($1,000 &times; the
underlying return of the worst performing underlying on the valuation date) + the final coupon payment</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">= $1,000 + ($1,000 &times; -70%) + the final coupon
payment</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">= $1,000 + -$700 + $21.50</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">= $321.50</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">In this scenario, you would receive significantly
less than the stated principal amount of your securities at maturity. You would incur a loss based on the performance of the worst performing
underlying on the valuation date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><FONT STYLE="font-weight: normal">Summary Risk Factors</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the securities is significantly riskier than an investment
in conventional debt securities. The securities are subject to all of the risks associated with an investment in our conventional debt
securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the securities,
and are also subject to risks associated with each underlying. Accordingly, the securities are suitable only for investors who are capable
of understanding the complexities and risks of the securities. You should consult your own financial, tax and legal advisors as to the
risks of an investment in the securities and the suitability of the securities in light of your particular circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the securities. You should read this summary together with the more detailed description of risks relating to an investment in the
securities contained in the section &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 in the accompanying product
supplement. You should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents incorporated
by reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and any subsequent
Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><FONT STYLE="background-color: white"><B>You may lose some or all of your investment.</B> Unlike conventional debt securities, the
securities do not provide for the repayment of the stated principal amount at maturity in all circumstances. If the securities are not
automatically redeemed prior to maturity, your payment at maturity will depend on the performance of the worst performing underlying on
the valuation date. If the </FONT>final underlying value <FONT STYLE="background-color: white">of the worst performing underlying on the
valuation date is less than its downside threshold value, a downside event will occur and you will lose 1% of the stated principal amount
of the securities for every 1% by which the worst performing underlying on the valuation date has declined from its initial underlying
value, regardless of the performance of the other underlyings. There is no minimum payment at maturity on the securities (excluding the
final coupon payment), and you may lose up to all of your investment. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The securities may be automatically redeemed prior to maturity, limiting your opportunity to receive coupon payments.</B> On any
potential autocall date, the securities will be automatically called for redemption if the closing value of the worst performing underlying
on that potential autocall date is greater than or equal to its initial underlying value. As a result, if the worst performing underlying
performs in a way that would otherwise be favorable, the securities are likely to be automatically redeemed, cutting short your opportunity
to receive coupon payments. If the securities are automatically redeemed prior to maturity, you may not be able to reinvest your funds
in another investment that provides a similar yield with a similar level of risk.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>Higher coupon payment rates are associated with greater risk.</B> The securities offer coupon payments at a per annum rate that
is higher than the rate we would pay on conventional debt securities of the same maturity. In exchange for this higher coupon payment
rate, investors in the securities will be subject to significantly greater risk than investors in our conventional debt securities, including
the risk that you may lose a significant portion, and up to all, of your investment at maturity (excluding the final coupon payment).
The volatility of and the correlation between the underlyings are important factors affecting these risks. In general, the higher the
expected volatility of the underlyings, and the lower the expected correlation between the underlyings, the greater the coupon payment
rate on the securities. However, higher expected volatility and lower expected correlation would also represent a greater expected likelihood
as of the pricing date that the final underlying value of the worst performing underlying on the valuation date will be less than its
downside threshold value, such that you will not be repaid the stated principal amount of your securities at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The securities are subject to heightened risk because they have multiple underlyings. </B>The securities are more risky than similar
investments that may be available with only one underlying. With multiple underlyings, there is a greater chance that any one underlying
will perform poorly, adversely affecting your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The securities are subject to the risks of each of the underlyings and will be negatively affected if any one underlying performs
poorly.</B> You are subject to risks associated with each of the underlyings. If any one underlying performs poorly, you will be negatively
affected. The securities are not linked to a basket composed of the underlyings, where the blended performance of the underlyings would
be better than the performance of the worst performing underlying alone. Instead, you are subject to the full risks of whichever of the
underlyings is the worst performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>You will not benefit in any way from the performance of any better performing underlying. </B>The return on the securities depends
solely on the performance of the worst performing underlying, and you will not benefit in any way from the performance of any better performing
underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>You will be subject to risks relating to the relationship between the underlyings.</B> It is preferable from your perspective for
the underlyings to be correlated with each other, in the sense that their closing values tend to increase or decrease at similar times
and by similar magnitudes. By investing in the securities, you assume the risk that the underlyings will not exhibit this relationship.
The less correlated the underlyings, the more likely it is that any one of the underlyings will perform poorly over the term of the securities.
All that is necessary for the securities to perform poorly is for one of the underlyings to perform poorly. It is impossible to predict
what the relationship between the underlyings will be over the term of the securities. <B>The underlyings differ in significant ways and,
therefore, may not be correlated with each other.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The securities offer downside exposure to the worst performing underlying, but no upside exposure to any underlying.</B> You will
not participate in any appreciation in the value of any underlying over the term of the securities. Consequently, your return on the securities
will be limited to the coupon payments and may be significantly less than the return on any underlying over the</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">term of the securities. In addition, as an investor in the
securities, you will not receive any dividends or other distributions or have any other rights with respect to any of the underlyings.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The performance of the securities will depend on the closing values of the underlyings solely on the potential autocall dates and
the valuation date, which makes the securities particularly sensitive to volatility in the closing values of the underlyings on or near
the potential autocall dates and the valuation date.</B> Whether the securities will be automatically redeemed prior to maturity will
depend on the closing values of the underlyings solely on the potential autocall dates, regardless of the closing values of the underlyings
on other days during the term of the securities. If the securities are not automatically redeemed prior to maturity, what you receive
at maturity will depend solely on the closing value of the worst performing underlying on the valuation date, and not on any other day
during the term of the securities. Because the performance of the securities depends on the closing values of the underlyings on a limited
number of dates, the securities will be particularly sensitive to volatility in the closing values of the underlyings on or near the potential
autocall dates and the valuation date. You should understand that the closing value of each underlying has historically been highly volatile.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc. </B>If we default on
our obligations under the securities and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything owed to you
under the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity. </B>The securities
will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities. CGMI currently
intends to make a secondary market in relation to the securities and to provide an indicative bid price for the securities on a daily
basis. Any indicative bid price for the securities provided by CGMI will be determined in CGMI&rsquo;s sole discretion, taking into account
prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the securities can be sold at that
price, or at all. CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and for
any reason. If CGMI suspends or terminates making a market, there may be no secondary market at all for the securities because it is likely
that CGMI will be the only broker-dealer that is willing to buy your securities prior to maturity. Accordingly, an investor must be prepared
to hold the securities until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The estimated value of the securities on the pricing date, based on CGMI&rsquo;s proprietary pricing models and our internal funding
rate, is less than the issue price</B>. The difference is attributable to certain costs associated with selling, structuring and hedging
the securities that are included in the issue price. These costs include (i) any selling concessions or other fees paid in connection
with the offering of the securities, (ii) hedging and other costs incurred by us and our affiliates in connection with the offering of
the securities and (iii) the expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates in connection
with hedging our obligations under the securities. These costs adversely affect the economic terms of the securities because, if they
were lower, the economic terms of the securities would be more favorable to you. The economic terms of the securities are also likely
to be adversely affected by the use of our internal funding rate, rather than our secondary market rate, to price the securities. See
&ldquo;The estimated value of the securities would be lower if it were calculated based on our secondary market rate&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The estimated value of the securities was determined for us by our affiliate using proprietary pricing models. </B> CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models. In doing so, it may have
made discretionary judgments about the inputs to its models, such as the volatility of, and correlation between, the closing values of
the underlyings, the dividend yields on the underlyings and interest rates. CGMI&rsquo;s views on these inputs may differ from your or
others&rsquo; views, and as an underwriter in this offering, CGMI&rsquo;s interests may conflict with yours. Both the models and the inputs
to the models may prove to be wrong and therefore not an accurate reflection of the value of the securities. Moreover, the estimated value
of the securities set forth on the cover page of this pricing supplement may differ from the value that we or our affiliates may determine
for the securities for other purposes, including for accounting purposes. You should not invest in the securities because of the estimated
value of the securities. Instead, you should be willing to hold the securities to maturity irrespective of the initial estimated value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The estimated value of the securities would be lower if it were calculated based on our secondary market rate.</B> The estimated
value of the securities included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which
we are willing to borrow funds through the issuance of the securities. Our internal funding rate is generally lower than our secondary
market rate, which is the rate that CGMI will use in determining the value of the securities for purposes of any purchases of the securities
from you in the secondary market. If the estimated value included in this pricing supplement were based on our secondary market rate,
rather than our internal funding rate, it would likely be lower. We determine our internal funding rate based on factors such as the costs
associated with the securities, which are generally higher than the costs associated with conventional debt securities, and our liquidity
needs and preferences. Our internal funding rate is not an interest rate that is payable on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">Because there is not an active market for traded instruments
referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of traded instruments
referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the securities, but subject
to adjustments that CGMI makes in its sole discretion. As a result, our secondary market rate is not a market-determined measure of our
creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness as adjusted for discretionary
factors such as CGMI&rsquo;s preferences with respect to purchasing the securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&squarf;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>The estimated value of the securities is not an indication of the price, if any, at which CGMI or any other person may be willing
to buy the securities from you in the secondary market.</B> Any such secondary market price will fluctuate over the term of the securities
based on the market and other factors described in the next risk factor. Moreover, unlike the estimated value included in this pricing
supplement, any value of the securities determined for purposes of a secondary market transaction will be based on our secondary market
rate, which will likely result in a lower value for the securities than if our internal funding rate were used. In addition, any secondary
market price for the securities will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount
of the securities to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions.
As a result, it is likely that any secondary market price for the securities will be less than the issue price.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The value of the securities prior to maturity will fluctuate based on many unpredictable factors. </B>The value of your securities
prior to maturity will fluctuate based on the closing values of the underlyings, the volatility of, and correlation between, the closing
values of the underlyings, dividend yields on the underlyings, interest rates generally, the time remaining to maturity and our and Citigroup
Inc.&rsquo;s creditworthiness, as reflected in our secondary market rate, among other factors described under &ldquo;Risk Factors Relating
to the Securities&mdash;Risk Factors Relating to All Securities&mdash;The value of your securities prior to maturity will fluctuate based
on many unpredictable factors&rdquo; in the accompanying product supplement. Changes in the closing values of the underlyings may not
result in a comparable change in the value of your securities. You should understand that the value of your securities at any time prior
to maturity may be significantly less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment. </B>The amount of this temporary upward
adjustment will steadily decline to zero over the temporary adjustment period. See &ldquo;Valuation of the Securities&rdquo; in this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The FTSE MIB Index, the Nikkei 225 Index and the EURO STOXX<SUP>&reg;</SUP> Banks Index are subject to risks associated with non-U.S.
markets.</B> Investments in securities linked to the value of non-U.S. stocks involve risks associated with the securities markets in
those countries, including risks of volatility in those markets, governmental intervention in those markets and cross shareholdings in
companies in certain countries. Also, there is generally less publicly available information about companies in some of these jurisdictions
than about U.S. companies that are subject to the reporting requirements of the SEC. Further, non-U.S. companies are generally subject
to accounting, auditing and financial reporting standards and requirements and securities trading rules that are different from those
applicable to U.S. reporting companies. The prices of securities in foreign markets may be affected by political, economic, financial
and social factors in those countries, or global regions, including changes in government, economic and fiscal policies and currency exchange
laws. Moreover, the economies in such countries may differ favorably or unfavorably from the economy of the United States in such respects
as growth of gross national product, rate of inflation, capital reinvestment, resources and self-sufficiency.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The performance of the FTSE MIB Index and the EURO STOXX<SUP>&reg;</SUP> Banks Index will not be adjusted for changes in the exchange
rate between the euro and the U.S. dollar.</B> The FTSE MIB Index and the EURO STOXX<SUP>&reg;</SUP> Banks Index are composed of stocks
traded in euro, the value of which may be subject to a high degree of fluctuation relative to the U.S. dollar. However, the performance
of the FTSE MIB Index and the EURO STOXX<SUP>&reg;</SUP> Banks Index and the value of your securities will not be adjusted for exchange
rate fluctuations. If the euro appreciates relative to the U.S. dollar over the term of the securities, your return on the securities
will underperform an alternative investment that offers exposure to that appreciation in addition to the changes in the levels of the
FTSE MIB Index and the EURO STOXX<SUP>&reg;</SUP> Banks Index.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The performance of the Nikkei 225 Index will not be adjusted for changes in the exchange rate between the Japanese yen and the
U.S. dollar.</B> The Nikkei 225 Index is composed of stocks traded in Japanese yen, the value of which may be subject to a high degree
of fluctuation relative to the U.S. dollar. However, the performance of the Nikkei 225 Index and the value of your securities will not
be adjusted for exchange rate fluctuations. If the Japanese yen appreciates relative to the U.S. dollar over the term of the securities,
your return on the securities will underperform an alternative investment that offers exposure to that appreciation in addition to the
change in the level of the Nikkei 225 Index.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The Russell 2000<SUP>&reg;</SUP> Index is subject to risks associated with small capitalization stocks.</B> The stocks that constitute
the Russell 2000<SUP>&reg;</SUP> Index are issued by companies with relatively small market capitalization. The stock prices of smaller
companies may be more volatile than stock prices of large capitalization companies. These companies tend to be less well-established than
large market capitalization companies. Small capitalization companies may be less able to withstand adverse economic, market, trade and
competitive conditions relative to larger companies. Small capitalization companies are less likely to pay dividends on their stocks,
and the presence of a dividend payment could be a factor that limits downward stock price pressure under adverse market conditions.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>Our offering of the securities is not a recommendation of any underlying. </B>The fact that we are offering the securities does
not mean that we believe that investing in an instrument linked to the underlyings is likely to achieve favorable returns. In fact, as
we are part of a global financial institution, our affiliates may have positions (including short positions) in the underlyings or in
instruments related to the underlyings, and may publish research or express opinions, that in each case are inconsistent with an investment
linked to the underlyings. These and other activities of our affiliates may affect the closing values of the underlyings in a way that
negatively affects the value of and your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The closing value of an underlying may be adversely affected by our or our affiliates&rsquo; hedging and other trading activities.</B>
We have hedged our obligations under the securities through CGMI or other of our affiliates, who have taken positions in the</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">underlyings or in financial instruments
related to the underlyings and may adjust such positions during the term of the securities. Our affiliates also take positions in the
underlyings or in financial instruments related to the underlyings on a regular basis (taking long or short positions or both), for their
accounts, for other accounts under their management or to facilitate transactions on behalf of customers. These activities could affect
the closing values of the underlyings in a way that negatively affects the value of and your return on the securities. They could also
result in substantial returns for us or our affiliates while the value of the securities declines.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>We and our affiliates may have economic interests that are adverse to yours as a result of our affiliates&rsquo; business activities.</B>
Our affiliates engage in business activities with a wide range of companies. These activities include extending loans, making and facilitating
investments, underwriting securities offerings and providing advisory services. These activities could involve or affect the underlyings
in a way that negatively affects the value of and your return on the securities. They could also result in substantial returns for us
or our affiliates while the value of the securities declines. In addition, in the course of this business, we or our affiliates may acquire
non-public information, which will not be disclosed to you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the securities.</B>&nbsp;
If certain events occur during the term of the securities, such as market disruption events and other events with respect to an underlying,
CGMI, as calculation agent, will be required to make discretionary judgments that could significantly affect your return on the securities.
In making these judgments, the calculation agent&rsquo;s interests as an affiliate of ours could be adverse to your interests as a holder
of the securities. See &ldquo;Risk Factors Relating to the Securities&mdash;Risk Factors Relating to All Securities&mdash;The calculation
agent, which is an affiliate of ours, will make important determinations with respect to the securities&rdquo; in the accompanying product
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>Changes that affect the underlyings may affect the value of your securities.</B> The sponsors of the underlyings may at any time
make methodological changes or other changes in the manner in which they operate that could affect the values of the underlyings. We are
not affiliated with any such underlying sponsor and, accordingly, we have no control over any changes any such sponsor may make. Such
changes could adversely affect the performance of the underlyings and the value of and your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The U.S. federal tax consequences of an investment in the securities are unclear.</B> There is no direct legal authority regarding
the proper U.S. federal tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service (the
&ldquo;IRS&rdquo;). Consequently, significant aspects of the tax treatment of the securities are uncertain, and the IRS or a court might
not agree with the treatment of the securities as described in &ldquo;United States Federal Tax Considerations&rdquo; below. If the IRS
were successful in asserting an alternative treatment of the securities, the tax consequences of the ownership and disposition of the
securities might be materially and adversely affected. Moreover, future legislation, Treasury regulations or IRS guidance could adversely
affect the U.S. federal tax treatment of the securities, possibly retroactively.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">As described in &ldquo;United States Federal Tax Considerations&rdquo;
below, in connection with any information reporting requirements we may have in respect of the securities under applicable law, we intend
to treat a portion of each coupon payment as attributable to interest and the remainder to option premium. However, in light of the uncertain
treatment of the securities, it is possible that other persons having withholding or information reporting responsibility in respect of
the securities may treat a security differently, for instance, by treating the entire coupon payment as ordinary income at the time received
or accrued by a holder and/or treating some or all of each coupon payment on a security to a non-U.S. investor as subject to withholding
tax at a rate of 30%.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in"><B>If withholding applies to the securities, we will not
be required to pay any additional amounts with respect to amounts withheld.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">Information About the FTSE MIB Index</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The FTSE MIB Index measures the performance of 40 shares listed on the
Borsa Italiana (BIt) and seeks to replicate the broad sector weights of the Italian stock market. For additional information about the
FTSE MIB Index, see Annex A to this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding the FTSE MIB Index from publicly
available information and have not independently verified any information regarding the FTSE MIB Index. This pricing supplement relates
only to the securities and not to the FTSE MIB Index. We make no representation as to the performance of the FTSE MIB Index over the term
of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the FTSE MIB Index is not involved in any way in this offering and has no obligation
relating to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #59AE43; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="color: #59AE43; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the FTSE MIB Index on October 31, 2025 was 43,175.32.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of the FTSE MIB Index for each
day such value was available from January 2, 2015 to October 31, 2025. We obtained the closing values from Bloomberg L.P., without independent
verification. You should not take the historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"><B>FTSE MIB Index &ndash; Historical
    Closing Values</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"><B>January 2, 2015 to October 31,
    2025</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center; font-size: 10pt"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">Information About the Nikkei 225 Index</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Nikkei 225 Index is a stock index that measures the composite price
performance of selected Japanese stocks. The Nikkei 225 Index is currently based on 225 underlying stocks trading on the Tokyo Stock Exchange
representing a broad cross-section of Japanese industries. Non-ordinary shares, such as shares of ETFs, REITs, preferred stock or other
preferred securities or tracking stocks, are excluded from the Nikkei 225 Index. It is calculated and maintained by Nikkei Inc.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;The
Nikkei 225 Index&rdquo; in the accompanying underlying supplement for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding the Nikkei 225 Index from
publicly available information and have not independently verified any information regarding the Nikkei 225 Index. This pricing supplement
relates only to the securities and not to the Nikkei 225 Index. We make no representation as to the performance of the Nikkei 225 Index
over the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the Nikkei 225 Index is not involved in any way in this offering and has no obligation
relating to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #59AE43; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="color: #59AE43; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the Nikkei 225 Index on October 31, 2025 was 52,411.34.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of the Nikkei 225 Index for
each day such value was available from January 2, 2015 to October 31, 2025. We obtained the closing values from Bloomberg L.P., without
independent verification. You should not take the historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"><B>Nikkei 225 Index &ndash; Historical
    Closing Values</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"><B>January 2, 2015 to October 31,
    2025</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center; font-size: 10pt"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">Information About the Russell 2000<SUP>&reg; </SUP>Index</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Russell 2000<SUP>&reg;</SUP> Index is designed to track the performance
of the small capitalization segment of the U.S. equity market. All stocks included in the Russell 2000<SUP>&reg;</SUP> Index are traded
on a major U.S. exchange. It is calculated and maintained by FTSE Russell.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;The
Russell Indices&rdquo; in the accompanying underlying supplement for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding the Russell 2000<SUP>&reg;</SUP>
Index from publicly available information and have not independently verified any information regarding the Russell 2000<SUP>&reg;</SUP>
Index. This pricing supplement relates only to the securities and not to the Russell 2000<SUP>&reg;</SUP> Index. We make no representation
as to the performance of the Russell 2000<SUP>&reg;</SUP> Index over the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the Russell 2000<SUP>&reg;</SUP> Index is not involved in any way in this offering
and has no obligation relating to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #59AE43; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="color: #59AE43; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the Russell 2000<SUP>&reg;</SUP> Index on October
31, 2025 was <FONT STYLE="background-color: white">2,479.381</FONT>.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of the Russell 2000<SUP>&reg;</SUP>
Index for each day such value was available from January 2, 2015 to October 31, 2025. We obtained the closing values from Bloomberg L.P.,
without independent verification. You should not take the historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"><B>Russell 2000<SUP>&reg;</SUP>
    Index &ndash; Historical Closing Values</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"><B>January 2, 2015 to October 31,
    2025</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center; font-size: 10pt"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in; color: #59AE40">Information About the EURO STOXX<SUP>&reg;</SUP>
Banks Index</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in; color: #59AE40">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The EURO STOXX<SUP>&reg;</SUP> Banks Index includes companies in the
banks supersector within the STOXX<SUP>&reg;</SUP> Europe 600 Index, which tracks companies providing a broad range of financial services,
including retail banking, loans and money transmissions. The STOXX Europe 600<SUP>&reg;</SUP> Supersector indices contain the 600 largest
stocks traded on the major exchanges of 18 European countries. The EURO STOXX<SUP>&reg;</SUP> Banks Index is reported by Bloomberg L.P.
under the ticker symbol &ldquo;SX7E.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">STOXX Limited (&ldquo;STOXX&rdquo;) and its licensors and CGMI have
entered into a non-exclusive license agreement providing for the license to CGMI and its affiliates, in exchange for a fee, of the right
to use the EURO STOXX<SUP>&reg;</SUP> Banks Index, which is owned and published by STOXX, in connection with certain financial instruments,
including the notes. For more information, see &ldquo;Equity Index Descriptions&mdash;The STOXX Benchmark Indices&mdash;License Agreement&rdquo;
in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;The
STOXX Benchmark Indices&rdquo; in the accompanying underlying supplement for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding the EURO STOXX<SUP>&reg;</SUP>
Banks Index from publicly available information and have not independently verified any information regarding the EURO STOXX<SUP>&reg;</SUP>
Banks Index. This pricing supplement relates only to the securities and not to the EURO STOXX<SUP>&reg;</SUP> Banks Index. We make no
representation as to the performance of the EURO STOXX<SUP>&reg;</SUP> Banks Index over the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the EURO STOXX<SUP>&reg;</SUP> Banks Index is not involved in any way in this
offering and has no obligation relating to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #59AE43; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="color: #59AE43; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the EURO STOXX<SUP>&reg;</SUP> Banks Index on October
31, 2025 was <FONT STYLE="background-color: white">233.41.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of the EURO STOXX<SUP>&reg;</SUP>
Banks Index for each day such value was available from January 2, 2015 to October 31, 2025. We obtained the closing values from Bloomberg
L.P., without independent verification. You should not take the historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"><B>EURO STOXX<SUP>&reg;</SUP> Banks
    Index &ndash; Historical Closing Values</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"><B>January 2, 2015 to October 31,
    2025</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE40"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center; font-size: 10pt"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><FONT STYLE="font-weight: normal">United States Federal
Tax Considerations</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read carefully the discussion under &ldquo;United States
Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement and
&ldquo;Summary Risk Factors&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Due to the lack of any controlling legal authority, there is substantial
uncertainty regarding the U.S. federal tax consequences of an investment in the securities. In connection with any information reporting
requirements we may have in respect of the securities under applicable law, we intend (in the absence of an administrative determination
or judicial ruling to the contrary) to treat a security as a put option (the &ldquo;Put Option&rdquo;) written by you with respect to
the underlying shares, secured by a cash deposit equal to the stated principal amount of the security (the &ldquo;Deposit&rdquo;). In
the opinion of our counsel, Davis Polk &amp; Wardwell LLP, which is based on current market conditions, this treatment of the securities
is reasonable under current law; however, our counsel has advised us that it is unable to conclude affirmatively that this treatment is
more likely than not to be upheld, and that alternative treatments are possible. Under this treatment:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>a portion of each coupon payment made with respect to the securities will be attributable to interest on the Deposit; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the remainder will represent premium attributable to your grant of the Put Option (&ldquo;Put Premium&rdquo;).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We will treat 44.85% of each coupon payment as interest on the Deposit
and 55.15% as Put Premium.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming the treatment of a security as a Put Option and a Deposit is
respected, amounts treated as interest on the Deposit should be taxed as ordinary interest income, while the Put Premium should not be
taken into account prior to maturity or disposition of the securities. See &ldquo;United States Federal Tax Considerations&mdash;Tax Consequences
to U.S. Holders&rdquo; in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We do not plan to request a ruling from the IRS regarding the treatment
of the securities. An alternative characterization of the securities could materially and adversely affect the tax consequences of ownership
and disposition of the securities, including the timing and character of income recognized. In addition, the U.S. Treasury Department
and the IRS requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo;
and similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance.
Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury
regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences
of an investment in the securities, possibly with retroactive effect. You should consult your tax adviser regarding possible alternative
tax treatments of the securities and potential changes in applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Non-U.S. Holders. </B>Subject to the discussions below and in the
section of the accompanying product supplement entitled &ldquo;United States Federal Tax Considerations,&rdquo; if you are a Non-U.S.
Holder (as defined in the accompanying product supplement) of the securities, under current law you generally should not be subject to
U.S. federal withholding or income tax in respect of any amount paid to you with respect to the securities, provided that (i) income in
respect of the securities is not effectively connected with your conduct of a trade or business in the United States, and (ii) you comply
with the applicable certification requirements.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax
Consequences to Non-U.S. Holders&mdash;Dividend Equivalents under Section 871(m) of the Code&rdquo; in the accompanying product supplement,
Section 871(m) of the Internal Revenue Code of 1986, as amended, and Treasury regulations promulgated thereunder (&ldquo;Section 871(m)&rdquo;)
generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S. Holders with respect to certain financial
instruments linked to U.S. equities (&ldquo;Underlying Securities&rdquo;) or indices that include Underlying Securities. Section 871(m)
generally applies to instruments that substantially replicate the economic performance of one or more Underlying Securities, as determined
based on tests set forth in the applicable Treasury regulations. However, the regulations, as modified by an IRS notice, exempt financial
instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo; of one. Based on the terms of the securities and representations
provided by us, our counsel is of the opinion that the securities should not be treated as transactions that have a &ldquo;delta&rdquo;
of one within the meaning of the regulations with respect to any Underlying Security and, therefore, should not be subject to withholding
tax under Section 871(m).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">A determination that the securities are not subject
to Section 871(m) is not binding on the IRS, and the IRS may disagree with this treatment. Moreover, Section 871(m) is complex and its
application may depend on your particular circumstances, including your other transactions. You should consult your tax adviser regarding
the potential application of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>While we currently do not intend to withhold on payments on the securities
to Non-U.S. Holders (subject to compliance with the applicable certification requirements and the discussion in the accompanying product
supplement regarding &ldquo;FATCA&rdquo;), in light of the uncertain treatment of the securities other persons having withholding or information
reporting responsibility in respect of the securities may treat some or all of each coupon payment on a security as subject to withholding
tax at a rate of 30%. Moreover, it is possible that in the future we may determine that we should withhold at a rate of 30% on coupon
payments on the securities. We will not be required to pay any additional amounts with respect to amounts withheld.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement. The preceding discussion, when read in combination with that section,
constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning and disposing
of the securities.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under the laws
of any state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><FONT STYLE="font-weight: normal">Supplemental Plan
of Distribution</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the
underwriter of the sale of the securities, is acting as principal and will receive an underwriting fee of $28.50 for each security sold
in this offering. From this underwriting fee, CGMI will pay selected dealers not affiliated with CGMI a fixed selling concession of $28.50
for each security they sell. For the avoidance of doubt, the fees and selling concessions described in this pricing supplement will not
be rebated if the securities are automatically redeemed prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">See &ldquo;Plan of Distribution; Conflicts of Interest&rdquo; in the
accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying prospectus supplement and prospectus
for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><FONT STYLE="font-weight: normal">Valuation of the Securities</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the securities set forth on the
cover page of this pricing supplement based on proprietary pricing models. CGMI&rsquo;s proprietary pricing models generated an estimated
value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate the payout on
the securities, which consists of a fixed-income bond (the &ldquo;bond component&rdquo;) and one or more derivative instruments underlying
the economic terms of the securities (the &ldquo;derivative component&rdquo;). CGMI calculated the estimated value of the bond component
using a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary
derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various
inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of the securities prior to maturity will fluctuate
based on many unpredictable factors&rdquo; in this pricing supplement, but not including our or Citigroup Inc.&rsquo;s creditworthiness.
These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For a period of approximately three months following issuance of the
securities, the price, if any, at which CGMI would be willing to buy the securities from investors, and the value that will be indicated
for the securities on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one
or more financial information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.
This temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the
term of the securities. The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the three-month
temporary adjustment period. However, CGMI is not obligated to buy the securities from investors at any time. See &ldquo;Summary Risk
Factors&mdash;The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><FONT STYLE="font-weight: normal">Validity of the Securities</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Davis Polk &amp; Wardwell LLP, as special products
counsel to Citigroup Global Markets Holdings Inc., when the securities offered by this pricing supplement have been executed and issued
by Citigroup Global Markets Holdings Inc. and authenticated by the trustee pursuant to the indenture, and delivered against payment therefor,
such securities and the related guarantee of Citigroup Inc. will be valid and binding obligations of Citigroup Global Markets Holdings
Inc. and Citigroup Inc., respectively, enforceable in accordance with their respective terms, subject to applicable bankruptcy, insolvency
and similar laws affecting creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general applicability
(including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses
no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed
above. This opinion is given as of the date of this pricing supplement and is limited to the laws of the State of New York, except that
such counsel expresses no opinion as to the application of state securities or Blue Sky laws to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In giving this opinion, Davis Polk &amp; Wardwell LLP has assumed the
legal conclusions expressed in the opinions set forth below of Alexia Breuvart, Secretary and General Counsel of Citigroup Global Markets
Holdings Inc., and Karen Wang, Senior Vice President &ndash; Corporate Securities Issuance Legal of Citigroup Inc. In addition, this opinion
is subject to the assumptions set forth in the letter of Davis Polk &amp; Wardwell LLP dated February 14, 2024, which has been filed as
an exhibit to a Current Report on Form 8-K filed by Citigroup Inc. on February 14, 2024, that the indenture has been duly authorized,
executed and delivered by, and is a valid, binding and enforceable agreement of, the trustee and that none of the terms of the securities
nor the issuance and delivery of the securities and the related guarantee, nor the compliance by Citigroup Global Markets Holdings Inc.
and Citigroup Inc. with the terms of the securities and the related guarantee respectively, will result in a violation of any provision
of any instrument or agreement then binding upon Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable, or any restriction
imposed by any court or governmental body having jurisdiction over Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Alexia Breuvart, Secretary and General Counsel of
Citigroup Global Markets Holdings Inc., (i) the terms of the securities offered by this pricing supplement have been duly established
under the indenture and the Board of Directors (or a duly authorized committee thereof) of Citigroup Global Markets Holdings Inc. has
duly authorized the issuance and sale of such securities and such authorization has not been modified or rescinded; (ii) Citigroup Global
Markets Holdings Inc. is validly existing and in good standing under the laws of the State of New York; (iii) the indenture has been duly
authorized, executed and delivered by Citigroup Global Markets Holdings Inc.; and (iv) the execution and delivery of such indenture and
of the securities offered by this pricing</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">supplement by Citigroup Global Markets Holdings Inc., and the performance
by Citigroup Global Markets Holdings Inc. of its obligations thereunder, are within its corporate powers and do not contravene its certificate
of incorporation or bylaws or other constitutive documents. This opinion is given as of the date of this pricing supplement and is limited
to the laws of the State of New York.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Alexia Breuvart, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Global Markets Holdings Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed
above. In such examination, she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures
(other than those of officers of Citigroup Global Markets Holdings Inc.), the authenticity of all documents submitted to her or such persons
as originals, the conformity to original documents of all documents submitted to her or such persons as certified or photostatic copies
and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Karen Wang, Senior Vice President &ndash; Corporate
Securities Issuance Legal of Citigroup Inc., (i) the Board of Directors (or a duly authorized committee thereof) of Citigroup Inc. has
duly authorized the guarantee of such securities by Citigroup Inc. and such authorization has not been modified or rescinded; (ii) Citigroup
Inc. is validly existing and in good standing under the laws of the State of Delaware; (iii) the indenture has been duly authorized, executed
and delivered by Citigroup Inc.; and (iv) the execution and delivery of such indenture, and the performance by Citigroup Inc. of its obligations
thereunder, are within its corporate powers and do not contravene its certificate of incorporation or bylaws or other constitutive documents.
This opinion is given as of the date of this pricing supplement and is limited to the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Karen Wang, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed above. In such examination,
she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures (other than those of officers
of Citigroup Inc.), the authenticity of all documents submitted to her or such persons as originals, the conformity to original documents
of all documents submitted to her or such persons as certified or photostatic copies and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><FONT STYLE="font-weight: normal">Contact</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Clients may contact their local brokerage representative. Third-party
distributors may contact Citi Structured Investment Sales at (212) 723-7005.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>&copy; </SUP>2025 Citigroup Global Markets Inc. All rights reserved.
Citi and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered throughout
the world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-align: center; color: #59AE43"><B>Annex A</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-align: center; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><B>The FTSE MIB Index</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">All information contained in this pricing supplement regarding the FTSE
MIB Index, including, without limitation, its make-up, method of calculation and changes in its components, has been derived from publicly
available information, without independent verification. This information reflects the policies of, and is subject to change by, FTSE
International Limited (&ldquo;FTSE&rdquo;). The FTSE MIB Index is calculated, maintained and published by FTSE. FTSE has no obligation
to continue to publish, and may discontinue publication of, the FTSE MIB Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The FTSE MIB Index is calculated in euros and is reported by Bloomberg
L.P. under the ticker symbol &ldquo;FTSEMIB.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The FTSE MIB Index is a benchmark index for the Italian equity markets
belonging to the FTSE Italia Index Series. Capturing approximately 80% of the domestic market capitalization, the FTSE MIB Index is comprised
of highly liquid companies in Italy.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The FTSE MIB Index measures the performance of 40 shares listed on the
Borsa Italiana (BIt) and seeks to replicate the broad sector weights of the Italian stock market. The FTSE MIB Index is derived from the
universe of stocks trading on the Blt Milan (MTA) and Euronext Milan (MIV) markets. The FTSE MIB Index is market capitalization-weighted
after adjusting constituents for float. Individual constituent weights are capped at 15%. Index constituents are categorized in accordance
with the Industry Classification Benchmark (ICB), the global standard for industry sector analysis.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The base value of the FTSE MIB Index was set at the level of the MIB
30 Index at the close of trading on October 31, 2003 (10,644). Historical values for the FTSE MIB Index have been back calculated to December
31, 1997 (24,402). The FTSE MIB Index is calculated on a real-time basis in EUR.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Eligible Securities</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The FTSE MIB Index constituent shares are selected from the broad Italian
equity universe. All stocks traded on the BIt MTA and MIV markets, except for savings shares (azioni di risparmio) and preferred shares,
are eligible for inclusion in the FTSE MIB Index. Preferred shares, however, may be eligible if the ordinary shares of a company are not
listed or have consistently less liquidity than the preferred shares.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Companies whose business is that of holding equity and other investments
(<I>e.g.</I>, investment trusts) which are classified as belonging to the Equity Investment Instruments Subsector within the ICB, and
non-equity investment vehicles which are classified as belonging to the Non-Equity Investment Instruments Subsector within the ICB are
not eligible for inclusion.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>Minimum Voting Rights</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Companies assigned a developed market nationality are required to have
greater than 5% of the company&rsquo;s voting rights (aggregated across all of its equity securities, including, where identifiable, those
that are not listed or trading) in the hands of unrestricted shareholders or they will be deemed ineligible for index inclusion. Emerging
market securities are not subject to this requirement. Companies whose business is that of holding equity and other investments classified
by the New Industry Classification Benchmark as Subsector Closed End Investments (30204000) and non-equity investment instruments classified
as belonging to the Open End and Miscellaneous Investment Vehicles (30205000) are not eligible for inclusion.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Existing constituents with a developed market nationality who do not
currently meet the above requirement have a 5 year grandfathering period to comply. If subsequently they continue to fail the minimum
voting rights requirement they will be removed from the FTSE MIB Index at the September 2022 review.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Index Qualification Criteria</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In order to identify a candidate pool for FTSE MIB Index constituent
selection, stocks are examined using the following general criteria:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>Market Capitalization</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The float-adjusted market capitalization is determined through an Investable
Weight Factor (IWF):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">IWF = 100% - Sum of the % of shareholdings held by restricted shareholders</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>Investability Weighting</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Constituents of the FTSE MIB Index are adjusted for free float and foreign
ownership limits. Free float restrictions include:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 12pt"><FONT STYLE="font-size: 10pt">&#61623;</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Shares held by public companies, non-listed subsidiaries of public companies,
    private companies, employee share plans (ESOP), or holding companies.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Shares held by foundations and endowments.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Shares directly owned by state, regional, municipal and local governments
    (excluding shares held by independently managed pension schemes for governments).</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&#61623;</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Shares held by individual holders disclosed within corporate filings, regardless of amount.</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; width: 24px; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; width: 24px; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Portfolio holdings (such as shares held by banks and trusts, finance companies, hedge funds, investment advisors, insurance companies, pension funds, investment management companies, brokerage firms, mutual funds or exchange traded funds) are generally not considered as restricted. However where a single portfolio holding is 30% or greater it will be regarded as strategic and therefore restricted. The shares will remain restricted until the holding falls below 30%.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Shares that are held by sovereign wealth funds where the holding is 10% or greater. The shares will remain restricted until the holding falls below 10%. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Shares that are held in treasury.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Shares held by private equity firms and venture capital funds where the holding is 10% or greater.&nbsp;&nbsp;The shares will remain restricted until the holding falls below 10%..</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">All shares where the holder is subject to a lock-in clause (for the duration of that clause).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">US eligible companies that conduct their initial public offering via a de-SPAC transaction will only be considered for index inclusion following expiry of the longest stated lock-up. Former SPACs will be evaluated at the quarterly review following the expiry of the lock-up within the stated data cut-off window.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">All shares where the holder has a stated incentive to retain the shares (e.g. bonus shares paid if holding is retained for a set period of time) will be removed from free float.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">&#61623;</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Shares that are subject to on-going contractual agreements (such as swaps) where they would ordinarily be treated as restricted.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">&#61623;</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Shares held by founders, promoters, former directors, founding venture capital and private equity firms, private companies and individuals (including employees)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>Initial weighting </I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Companies with a free float of 5% or below are excluded from the FTSE
MIB Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>Quarterly updates </I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In June, a constituent&rsquo;s free float is updated regardless of size.
No buffers are applied.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">At the March, September and December quarterly updates, a constituent
with a free float greater than 15% will have its free float updated if it moves by more than 3 percentage points above or below the existing
free float. A constituent with a free float of 15% or below will be subject to a 1 percentage point threshold. Quarterly updates to free
float will be applied after the close of business on the third Friday of March, June, September and December. The data cut-off for these
quarterly changes will be the close of business on the last business day of January, April, July and October, respectively.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Free float changes resulting from corporate events will not be subject
to the buffers as detailed above and will be implemented in line with the event.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Treasury shares are always excluded from the shares in issue, regardless
of their size. Shares with a free float of 5% or below are not eligible for inclusion in the FTSE MIB Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The primary sources of shareholder information for Italian companies
are Commissione Nazionale per le Societ&agrave; e la Borsa (&ldquo;CONSOB&rdquo;) and companies&rsquo; official communications (annual
report, quarterly reports and prospectuses).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The analysis is based on the total stake held by the ultimate shareholder.
In the case of stock lending contracts or nominee holdings, the analysis is based on the owner of shares and not on the person/entity
having the voting rights. In the case of shares lent to banks, the analysis is based on the owner of the shares and not on the bank, and
is independent of the allocation of voting rights.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Shares with a free float of 5% or below are not eligible for inclusion
in the FTSE MIB Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>Minimum voting rights </I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Companies assigned a developed market nationality are required to have
greater than 5% of the company&rsquo;s voting rights (aggregated across all of its equity securities, including, where identifiable, those
that are not listed or trading) in the hands of unrestricted shareholders or they will be deemed ineligible for index inclusion. Emerging
market securities are not subject to this requirement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The percentage of a company&rsquo;s voting rights in public hands is
calculated as:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><I><IMG SRC="image_005.jpg" ALT="" STYLE="height: 54px; width: 429px"></I></FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>Liquidity</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Liquidity is measured by the stock&rsquo;s 6-month value traded in euro,
on BIt order book markets and by number of days traded.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>Shares Outstanding</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The primary source of information for Italian shares is the BIt Official
List.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Periodic Review of Constituent Shares</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The FTSE MIB Index will be reviewed on a quarterly basis in March, June,
September and December using market data as at the close of business on the Monday 4 weeks prior to the review effective date. Any constituent
changes will be implemented after close of business on the third Friday in March, June, September and December of the review month. If
the third Friday of the review month is a holiday, the preceding closing days prices will be used. FTSE is responsible for publishing
the outcome of the periodic review.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The underlying universe for the FTSE MIB Index is all stocks trading
on the BIt MTA and MIV markets (except for preferred and saving shares).&nbsp;&nbsp;The FTSE MIB Index will consist of the 40 most liquid
and highly capitalized stocks listed on the Blt MTA and MIV markets.&nbsp;&nbsp;Foreign listed companies are eligible for inclusion in
the FTSE MIB Index only if they have complied with BIt requirements in terms of dissemination of information. The selection procedure
is based on size (free float adjusted market capitalization) and liquidity (six months turnover). FTSE, with the support of the FTSE Italia
Index Series Technical Committee is responsible for the implementation of the algorithm and will decide whether special circumstances
would warrant making an exceptional change to the index constituents.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The constituents of the FTSE MIB Index are capped at 15% at the time
of the quarterly reviews.&nbsp;&nbsp;Capping procedures are run on the Monday following the second Friday of March, June, September and
December, they are based on Friday closing prices and they are implemented after the close of trading of the third Friday of March, June,
September and December.&nbsp;&nbsp;Any constituents whose weights are greater than 15% are capped at 15%.&nbsp;&nbsp;The weights of all
lower ranking constituents are increased correspondingly. The weights of lower ranking constituents are then checked and if they exceed
15%, they are capped at 15%.&nbsp;&nbsp;This process is repeated until no constituent weight exceeds 15%.&nbsp;&nbsp;The weight of each
stock in the FTSE MIB Index is evaluated in terms of its adjusted market capitalization versus the FTSE MIB Index, and will be re-evaluated
at each quarterly review.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Changes to Constituent Shares</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>Additions</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An Index addition outside quarterly reviews generally is made only if
a vacancy is created by an index deletion. Index additions are made according to size and liquidity. A newly-listed company is added to
the FTSE MIB Index only when an appropriate vacancy occurs and is subject to proven liquidity for at least three months.&nbsp;&nbsp;An
exception may be made for extraordinary large global offerings where expected trading volume justifies inclusion.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>New listed companies</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Newly listed companies are eligible for inclusion in the FTSE MIB Index
at the quarterly review providing they have traded a minimum of 20 days. Newly listed companies whose capitalization is greater than or
equal to 3% of the current market capitalization of the FTSE Italia All-Share Index are added to the FTSE MIB Index with an extraordinary
revision, to be applied on the first day of listing. FTSE will announce the revision and will confirm it as soon as all required information
is available (start of trading date, shares in issues, free float, IPO price).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>Deletions</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Deletions outside quarterly reviews can occur due to acquisitions, mergers
and spin-offs, or bankruptcies and suspensions, if the relevant Index constituent no longer meets the criteria for inclusion or is no
longer representative of its industry group, in the following situations:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in"><I>Positive outcome of a tender offer</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For each tender offer, the FTSE Italia Index Series Technical Committee
will agree internally beforehand what the level of acceptance should be to determine whether a tender offer is successful or partially
successful, with consideration of the expected liquidity post-event.&nbsp;&nbsp;If the offer is partially successful and there is a change
in the IWF, a notice period of two trading days will be provided. If acceptances exceed the threshold identified by the FTSE Italia Index
Series Technical Committee, the constituent is removed from the FTSE MIB Index with two trading days notice. A replacement constituent
is added from a candidate list, also with two trading days notice.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in"><I>Significant and ascertained or presumed reduction
in liquidity or capitalization</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The constituent will be removed and replaced in a full rebalancing that
uses closing prices of all constituents.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;<I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whenever
the BIt, in accordance with BIt Rules, delists a constituent company (e.g., in cases of the involvement of the issuer in insolvency procedures
or in cases of the liquidation of the issuer) </I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The constituent is removed and replaced in a full rebalance that uses
the closing prices of all constituents.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in"><I>Suspended companies</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If FTSE Russell becomes aware that a constituent is suspended, index
treatment will be determined as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If a constituent is declared bankrupt without any indication
of compensation to shareholders, the last traded price will be adjusted down to zero value and it will subsequently be removed from the
FTSE MIB Index with T+2 notice.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>In all other cases, the constituent will continue to be included
in the FTSE MIB Index for a period of up to 20 business days at its last traded price.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If the constituent continues to be suspended at the end of that
period, it will be subject to review and a decision will be taken to either allow the constituent to remain in the FTSE MIB Index for
a further period of up to 20 business days or to remove it at zero value. In making this determination, FTSE will take into account the
stated reasons for the suspension. These reasons may include announcements made by the company regarding a pending acquisition or restructuring,
and any stated intentions regarding a date for the resumption of trading.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>This procedure will be repeated at successive 20 business day
intervals thereafter until either trading recommences or the suspension period reaches 80 business days.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If the suspension period reaches 80 business days and the constituent
has not announced a firm date for the resumption of trading during the 40 business day period, FTSE will provide notice that the constituent
will be removed at zero value at the next index review following the expiry of the 40 business day period.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>In certain limited circumstances where the index weight of the
constituent is significant and FTSE determines that a market-related value can be established for the suspended constituent, for example
because similar company securities continue to trade, deletion may take place at the market-related value instead. In such circumstances,
FTSE will set out its rationale for the proposed treatment of the constituent at the end of the 80 business day period.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If following the end of the 80 business day period, a suspended
constituent that has not announced a firm date for the resumption of trading nevertheless resumes trading before its planned removal
date, the constituent will continue to be removed from the FTSE MIB Index as previously announced but in these circumstances the deletion
will be implemented at market value.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If during the minimum 40 business day notice period, a suspended
constituent that had previously announced a firm date for the resumption of trading within that period then nevertheless fails to resume
trading on that date, FTSE will give notice that the constituent will be removed at the index review following the expiry of an additional
notice period of 40 business days.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If a constituent has been removed from the FTSE MIB Index and
trading is subsequently restored, the constituent will only be re-considered for inclusion after a period of 12 months from its deletion.
For the purposes of index eligibility it will be treated as a new issue.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in"><I>Mergers / Takeovers between Constituents</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the two merging companies, both the acquiring and the acquired, are
index constituents, the newly merged entity will be included in the FTSE MIB Index and a new constituent will be added to fill the gap
created by the merger.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in"><I>Mergers / Takeovers between a Constituent and
a Non-Constituent</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If a non-constituent acquires a current constituent of the FTSE MIB
Index, the latter will be removed from the FTSE MIB Index and will be replaced with a new constituent. The non-constituent acquiring the
company would be eligible for consideration if it qualifies in all other respects. FTSE will make an announcement detailing any index
change.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Weights of the constituents are based on the closing price and the number
of shares after the merger.&nbsp;&nbsp; When there is a merger, there will be a full rebalancing of the FTSE MIB Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Where a constituent company acquires a non-constituent for shares, or
a combination of cash and shares, the shares of the constituent company will only be updated to reflect the merger when the acquired company
is a FTSE Russell Universe member. Any share and/or free float update will be made giving appropriate notice. Where the acquired company
is not a FTSE Russell Universe member the shares in the acquiring constituent company will be reviewed at the next quarterly review.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Index Maintenance</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The maintenance of the FTSE MIB Index consists of corporate actions,
periodic revisions to the FTSE MIB Index and changes due to vacancies created by the deletion of a constituent of the FTSE MIB Index.
The maintenance activity is carried out by FTSE with the objective of minimizing the turnover among index constituents.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the event of an index change or corporate action resulting in a change
to shares in issue or free float for Index constituents that affects the market capitalization of the FTSE MIB Index, the divisor is adjusted
to ensure continuity of the FTSE MIB Index. The number of constituents in the FTSE MIB Index is analyzed at each quarterly review (March,
September, June and December) to assess whether the FTSE MIB Index adequately represents the market. If FTSE, with the support of the
FTSE Italia Index Series Technical Committee, decides the number of constituents needs to be changed, a change will be made after providing
the market with ample notice.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">At periodic reviews, the prices applied to all constituents of the index
are the closing prices of the third Friday of the rebalancing month.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>On rebalancing days (usually Friday), when the closing auction
price of one or more of the constituents in the FTSE MIB Index has not been set by the end of the closing auction session because there
is no match in the market, FTSE will use the reference price, defined by BIt as the volume weighted average price of trades in the last
10 minutes of the session (in the absence of trading in that period, the latest traded price in the session; in case of absence of trading,
the previous session reference price).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If the auction price is not valid, FTSE will use the reference
price.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If the constituent is suspended, FTSE will use the closing auction
price (in its absence, the reference price) set in the previous session, adjusted for any relevant corporate actions.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">All share and IWF changes are updated on a quarterly basis using the
closing prices on the evening of the third Friday of March, June, September and December, to coincide with the expiry of derivatives of
IDEM contracts.&nbsp;&nbsp;The FTSE MIB Index will be disseminated from the beginning of the next continuous trading session.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The 15% capping adjustment factors are adjusted at each quarterly rebalancing.
The capping numbers are calculated based on the closing prices on the second Friday of March, June, September and December, using the
share &amp; IWF numbers from the previous end of month. The announcement of the capping adjustments to the new IWFs is made alongside
the announcement of the new number of shares in issue at the close of trading, no later than the third business day before the effective
date, by way of a technical notice.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Following corporate actions (for example, mergers and capital increases)
which result in a change in the number of outstanding shares greater than 10%, the number of outstanding shares will be adjusted in the
FTSE MIB Index at the end of the corporate action period. All other changes to shares outstanding will occur at the quarterly review;
to prevent a large number of insignificant weighting changes, the number of shares in issue for each constituent is amended only when
the total shares in issue held within the index system changes by more than 1% on a cumulative basis. When there is a change larger than
10% in the number of shares or in the IWF of a constituent, the FTSE MIB Index will be adjusted to reflect the new market capitalization.
This change will be performed at the end of the day and will trigger a divisor update. In the case where a shares in issue or IWF change
is a result of a &ldquo;market wide event&rdquo; such as an institutional placement, sell down via a book build or partial takeover offer,
FTSE may decide to implement changes in IWF that are greater than 3%. All announcements regarding ongoing changes to shares and IWFs will
be done on a &ldquo;best efforts&rdquo; basis. While the primary source for IWF changes is CONSOB, public announcements of sell downs
and Patti di Sindacato changes by the companies themselves will be sourced where appropriate. Similarly, the BIt Official List is the
primary source for share changes. However, a public announcement of an institutional placement by a company or of the results of a capital
increase may call for FTSE to announce a change to shares outstanding prior to the Official List being updated.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Adjustments will also be made in the event of certain corporate actions
such as rights offerings, special dividends, splits, reverse splits and spin-offs.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;<B>Changes to the Classification of Constituent Shares</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;The FTSE MIB Index constituents are classified into Industries,
Supersectors, Sectors and Subsectors, as defined by the ICB.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Changes to the classification of a company within the FTSE MIB Index
will be advised by FTSE and the necessary adjustments will be made to the relevant industry sectors at the same time that the constituent
changes are implemented.&nbsp;&nbsp;Where a constituent is the subject of a merger, restructure or complex takeover which results in a
constituent (or part of a constituent) being absorbed by another, the industry classification of the resulting constituent(s) will be
reviewed by FTSE.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;Any adjustment resulting from a change in a company&rsquo;s classification
will be implemented at the same time that any relevant constituent changes are implemented in the FTSE MIB Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Periodic changes to the industry classification of a company are agreed
and announced by FTSE.&nbsp;&nbsp;Such changes will be implemented after the close of the index calculation on the next working day following
the third Friday of each month.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;<B>Index Calculation</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The FTSE MIB Index uses prices from actual trades on the MTA and MIV
electronic share trading platform of the BIt during official market hours.&nbsp;&nbsp;The last Index value is calculated using closing
auction prices or, if there is no closing auction price for a particular constituent, the last price traded as at the end of the continuous
trading phase. BIt&rsquo;s closing price is used by BIt&rsquo;s Market Supervision division in the calculation of K factors to be applied
to the FTSE MIB Index for corporate actions. BIt&rsquo;s reference price plays no part in the FTSE MIB Index calculation.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The FTSE MIB Index is calculated using a base-weighted aggregate methodology.&nbsp;&nbsp;This
means the level of an index reflects the total float-adjusted market value of all of the constituent stocks relative to a particular base
period.&nbsp;&nbsp;The total market value of a company is determined by multiplying the price of its stock by the number of shares in
issue (net of treasury shares) after adjusting for float.&nbsp;&nbsp;An indexed number is used to represent the result of this calculation
in order to make the value easier to work with and track over time.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The FTSE MIB Index value I<SUP>t</SUP>, at time t, is calculated using
the following formula:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">I<SUB>t</SUB> = M<SUB>t</SUB> / D<SUB>t</SUB></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE43 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43">&nbsp;</TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Where M<SUP>t</SUP> = total free float adjusted market capitalization
at time t, equal to:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">M<SUB>t</SUB> = &Sigma;<SUB>i</SUB> p<SUB>it</SUB>
x q<SUB>it</SUB> x IWF<SUB>it</SUB></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">And</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">p<SUP>it</SUP> = The last traded price, at time t, of the i<SUP>th</SUP>-share.
Where the shares of one of the constituents are suspended, the FTSE MIB Index is calculated using the price of the latest trade concluded
before the suspension.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">q<SUP>it</SUP> = Number of shares in the FTSE MIB Index. The number
of shares in issue for the security</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">i<SUP>th</SUP>, net of treasury shares.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">IWF<SUP>it</SUP> = Investable Weighting Factor (adjusted for capping)
for the i<SUP>th</SUP> share.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">D<SUP>t</SUP> = Value of the FTSE MIB Index divisor at time t.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white"><B>License Agreement</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">FTSE and Citigroup Global Markets Inc. have entered into a non-exclusive
license agreement providing for the license to Citigroup Inc. and its other affiliates, in exchange for a fee, of the right to use indices
owned and published by FTSE in connection with certain financial products, including the securities. All rights to the FTSE MIB Index
are owned by FTSE, the publisher of the FTSE MIB Index. Citigroup Global Markets Inc. and its affiliates disclaim all responsibility for
the calculation or other maintenance of or any adjustments to the FTSE MIB Index. In addition, none of the LSE, the Financial Times and
FTSE has any relationship to Citigroup Global Markets Inc. or the securities. None of the LSE, the Financial Times and FTSE sponsors,
endorses, authorizes, sells or promotes the securities, or has any obligation or liability in connection with the administration, marketing
or trading of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp236919_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.0a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: ef306dff5cd0f9a8e13ce7fb8967ac96 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024">
<head>
  <title>Filing Fees</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="ixv-211">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="ixv-212">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="ixv-213">0000831001</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="ixv-214">333-270327</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-04</xbrli:startDate>
          <xbrli:endDate>2025-11-04</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-04</xbrli:startDate>
          <xbrli:endDate>2025-11-04</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-04</xbrli:startDate>
          <xbrli:endDate>2025-11-04</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: right; font-weight: bold">Ex-Filing Fees</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold">CALCULATION OF FILING FEE TABLES</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="ixv-248">S-3</ix:nonNumeric></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; text-align: center; font-weight: bold">Citigroup Global Markets Holdings Inc.</p>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="ixv-249">Citigroup Inc</ix:nonNumeric>., as Guarantor</p>

<p style="border-top: Gray 3pt double; font-size: 11pt; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="ixv-250">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="ixv-251">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="ixv-253">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-254">400</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-255">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-256">400,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-257">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-258">55.24</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="ixv-259">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="ixv-260">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="ixv-262">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-263">0</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-264">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-265">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-266">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-267">0.00</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-268">400,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
 <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-269">55.24</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-270">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-271">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-272">55.24</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-weight: bold; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ix:nonNumeric></td></tr>
  </table>

<p style="border-top: Gray 3pt double; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-275">400,000</ix:nonFraction>. <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-276">The
prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ D$# 2(  A$! Q$!_\0
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MZ9')Q2_;-5_NV_\ WS_]E4VK_P#'SIO_ %W;_P!%/24 1?;-5_NV_P#WS_\
M94?;-5_NV_\ WS_]E4M% $7VS5?[MO\ ]\__ &5'VS5?[MO_ -\__95+10!%
M]LU7^[;_ /?/_P!E1]LU7^[;_P#?/_V52T4 1?;-5_NV_P#WS_\ 94?;-5_N
MV_\ WS_]E4M% $7VS5?[MO\ ]\__ &5'VS5?[MO_ -\__95+10!%]LU7^[;_
M /?/_P!E1]LU7^[;_P#?/_V52T4 1?;-5_NV_P#WS_\ 94?;-5_NV_\ WS_]
ME4M% $7VS5?[MO\ ]\__ &5'VS5?[MO_ -\__95+10!%]LU7^[;_ /?/_P!E
M1]LU7^[;_P#?/_V52T4 1?;-5_NV_P#WS_\ 94?;-5_NV_\ WS_]E4M% $7V
MS5?[MO\ ]\__ &5'VS5?[MO_ -\__95+10!%]LU7^[;_ /?/_P!E1]LU7^[;
M_P#?/_V52T4 1?;-5_NV_P#WS_\ 94?;-5_NV_\ WS_]E4M% $7VS5?[MO\
M]\__ &5'VS5?[MO_ -\__95+10!%]LU7^[;_ /?/_P!E1]LU7^[;_P#?/_V5
M2T4 1?;-5_NV_P#WS_\ 94?;-5_NV_\ WS_]E4M% $7VS5?[MO\ ]\__ &5'
MVS5?[MO_ -\__95+10!%]LU7^[;_ /?/_P!E1]LU7^[;_P#?/_V52T4 1?;-
M5_NV_P#WS_\ 94?;-5_NV_\ WS_]E4M% $7VS5?[MO\ ]\__ &5'VS5?[MO_
M -\__95+10!%]LU7^[;_ /?/_P!E1]LU7^[;_P#?/_V52T4 1?;-5_NV_P#W
MS_\ 94?;-5_NV_\ WS_]E4M% $7VS5?[MO\ ]\__ &5'VS5?[MO_ -\__95+
M10!%]LU7^[;_ /?/_P!E1]LU7^[;_P#?/_V52T4 1?;-5_NV_P#WS_\ 94?;
M-5_NV_\ WS_]E4M% $7VS5?[MO\ ]\__ &5'VS5?[MO_ -\__95+10!%]LU7
M^[;_ /?/_P!E1]LU7^[;_P#?/_V52T4 1?;-5_NV_P#WS_\ 94?;-5_NV_\
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M8)\I_45-Y+_\_$W_ ([_ (5-J_\ Q\Z;_P!=V_\ 13TE $7DO_S\3?\ CO\
MA1Y+_P#/Q-_X[_A4M% $7DO_ ,_$W_CO^%'DO_S\3?\ CO\ A4M% $7DO_S\
M3?\ CO\ A1Y+_P#/Q-_X[_A4M% $7DO_ ,_$W_CO^%'DO_S\3?\ CO\ A4M%
M $7DO_S\3?\ CO\ A1Y+_P#/Q-_X[_A4M% $7DO_ ,_$W_CO^%'DO_S\3?\
MCO\ A4M% $7DO_S\3?\ CO\ A1Y+_P#/Q-_X[_A4M% $7DO_ ,_$W_CO^%'D
MO_S\3?\ CO\ A4M% $7DO_S\3?\ CO\ A1Y+_P#/Q-_X[_A4M% $7DO_ ,_$
MW_CO^%'DO_S\3?\ CO\ A4M% $7DO_S\3?\ CO\ A1Y+_P#/Q-_X[_A4M% $
M7DO_ ,_$W_CO^%'DO_S\3?\ CO\ A4M% $7DO_S\3?\ CO\ A1Y+_P#/Q-_X
M[_A4M% $7DO_ ,_$W_CO^%'DO_S\3?\ CO\ A4M% $7DO_S\3?\ CO\ A1Y+
M_P#/Q-_X[_A4M% $7DO_ ,_$W_CO^%'DO_S\3?\ CO\ A4M% $7DO_S\3?\
MCO\ A1Y+_P#/Q-_X[_A4M% $7DO_ ,_$W_CO^%'DO_S\3?\ CO\ A4M% $7D
MO_S\3?\ CO\ A1Y+_P#/Q-_X[_A4M% $7DO_ ,_$W_CO^%'DO_S\3?\ CO\
MA4M% $7DO_S\3?\ CO\ A1Y+_P#/Q-_X[_A4M% $7DO_ ,_$W_CO^%'DO_S\
M3?\ CO\ A4M% $7DO_S\3?\ CO\ A1Y+_P#/Q-_X[_A4M% $7DO_ ,_$W_CO
M^%'DO_S\3?\ CO\ A4M% $7DO_S\3?\ CO\ A1Y+_P#/Q-_X[_A4M% $7DO_
M ,_$W_CO^%'DO_S\3?\ CO\ A4M% $7DO_S\3?\ CO\ A1Y+_P#/Q-_X[_A4
MM% $7DO_ ,_$W_CO^%'DO_S\3?\ CO\ A4M% $7DO_S\3?\ CO\ A1Y+_P#/
MQ-_X[_A4M% $7DO_ ,_$W_CO^%<]XBUPZ8IM[6[D^VJRDJ\8(VD>N/I735Y7
MK-R;O6+N4R-(OF%4+==H. *X\75=.'N[LY<55<(:;LW_ !5(]W::5Y$LDPN
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MI:* $V)_<7\J-B?W%_*EHH 38G]Q?RHV)_<7\J6B@!-B?W%_*C8G]Q?RI:*
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MW>AAB':%EUT.;^T7NI0VFFJOF>42L**H!.>Q]:C^W7$>G_8%9D19&8A3C.<
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M]O\ GWF_)?\ &@"6BHO/;_GWF_)?\://;_GWF_)?\: ):*B\]O\ GWF_)?\
M&CSV_P"?>;\E_P : ):*B\]O^?>;\E_QH\]O^?>;\E_QH EHJ+SV_P"?>;\E
M_P ://;_ )]YOR7_ !H EHJ+SV_Y]YOR7_&CSV_Y]YOR7_&@"6BHO/;_ )]Y
MOR7_ !H\]O\ GWF_)?\ &@"6BHO/;_GWF_)?\://;_GWF_)?\: ):*B\]O\
MGWF_)?\ &CSV_P"?>;\E_P : ):*B\]O^?>;\E_QH\]O^?>;\E_QH EHJ+SV
M_P"?>;\E_P ://;_ )]YOR7_ !H EHJ+SV_Y]YOR7_&CSV_Y]YOR7_&@"6BH
MO/;_ )]YOR7_ !J*XOX[2W>>XCECB3[S,!Q^M)NVK!NQ:HJM!?)<P)-!'+)$
MXRK*!@_K45_J L[":=XY(]J':6"_>QQWYH<DE<3:2N7'=8XWD?(1 68@= *Y
M;PQ+)J.MZIJF1Y;_ " =^N1^@K"*>(M7MDG_ -*N(F# %6P/0\#%==X>M)-,
MTB.&6TD6=B7DQM.2>G?TKBA4=:I%V:2U.2,W5FG:R6IM5%=Q^=9SQ$_?C9?S
M!H\]O^?>;\E_QI//;_GWF_)?\:[6KJQV/4Y[P/"$TB:;C,DV,]\ #_&NGJ$2
ME1@6TH'LJC^M+Y[?\^\WY+_C44H>S@H]B*<.2*CV):*B\]O^?>;\E_QH\]O^
M?>;\E_QK0LEHJ+SV_P"?>;\E_P ://;_ )]YOR7_ !H EH@_Y"D'_7*3^:5%
MY[?\^\WY+_C3K20OJL.8W3$4GW@.>5]#0!L4444 %%%<)XHU7Q7:>(A#I<4K
M6C1XB$<*.C.5/,C,05PVT=OE)/)H [F2-)49)$5T88*L,@TS[-;YB/D1YB_U
M9V#Y/IZ5(NXHI;&['..F:6@"%+2W1D=84WIG:Q7)7)R<'\:3[':F)XOLT/EN
MVYDV##'U([FIZ* ,K5@!<:: , 3M_P"BGHI=7_X^=-_Z[M_Z*>DH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBN,\9:E<0WT%K;7,L6V/>X1M
MO)/'3VK*M55*/,S.K45./,SL6DC5U1I$5F^ZI8 GZ#O3J\WUC6I=5FM)X$=&
MM(@3(.H;C)SZ9Q^==CH&N)K%J0V%NHQ^\0#C'8BLJ>)C.;BOEYF=/$1G)Q7R
M->BBBNHZ HHHH *,4R::.W@DGE)$<:EF(&< 5YK'K<[:Y%?7$LKQI-YGEJYP
M!Z =JYZU>-*R?4PJUE3LGU/3<'TKE_&&JK#;?V8D>^6=0S'^Z,\8]SBN<L_$
M=]97MS<J5E:<Y*RDD#G/ S3M,MKS7-<CGE625/,#RN3@!0>@/]*Y*F*]K'D@
MM6<T\3[2/)!:LC'B"_ATJ/3[>3RD0??08?.2>HJ_K&K0Z]'IMC LOFAE#N_]
MX@#IW]<UIQ^"K>)+LRS/.64^0%^4J>V?4]!6=X;TB_M=?A>[LI41%;+,N5!V
M\<]*R]G65H2V>GW&7)65H2V>AVEC9QZ?916D3,R1# +=3WJQ117KI)*R/422
M5D%%%%,84444 %%%% !1110 40?\A2#_ *Y2?S2BB#_D*0?]<I/YI0!JT444
M %>2>+A:ZWJUVXTE I A:YFT&YEG7;P2K@A2/3C%>MUY3XGM=,UO7IY+W4I]
M)NR5AB34X)%B"C(8HP8(<\,.>N<@@X !ZDA5+=26 55')XXQ^E(;F!=FZ:,>
M9]S+#YOIZU%=@)IYQ;&[VA<1+CYNGJ<>]9$>G2))!+!;3+*>F\)Y:?.68%>2
M.O&">WI0!OF1!((RZAV&0I/)_"F^?"$9_-CV*<,VX8!]#6-<6LUW>M)' V9'
M1HYV 'DA"0PZYYYZ?WJ@BT^9&BE;3V\J)426 !"96"N"^,X/+#KSQ0!H:O\
M\?&F_P#7=O\ T4])52YMIX+?1(6E"O&Y5OEW<^4]3>7/_P _ _[]#_&@"6BH
M$WR$A+R-RO4*@./UH<2QJ6>Z15'4M& /YT 3T5"$F89%RI'J(P?ZTOES_P#/
MP/\ OT/\: ):*B\N?_GX'_?H?XT>7/\ \_ _[]#_ !H EHJ+RY_^?@?]^A_C
M1Y<__/P/^_0_QH EHJ+RY_\ GX'_ 'Z'^-'ES_\ /P/^_0_QH EHJ+RY_P#G
MX'_?H?XT>7/_ ,_ _P"_0_QH EHJ+RY_^?@?]^A_C1Y<_P#S\#_OT/\ &@"6
MBHO+G_Y^!_WZ'^-'ES_\_ _[]#_&@"6BHO+G_P"?@?\ ?H?XT>7/_P _ _[]
M#_&@"6BL34]<72[ZWMIIP?-Y9P@_=C.,D=:UO+G_ .?@?]^A_C4J<6VD]B5)
M-M+H2T5%Y<__ #\#_OT/\:/+G_Y^!_WZ'^-442T5%Y<__/P/^_0_QH\N?_GX
M'_?H?XT 2T5%Y<__ #\#_OT/\:/+G_Y^!_WZ'^- $M%1>7/_ ,_ _P"_0_QH
M\N?_ )^!_P!^A_C0!+3%FB>5HEE1I$^\@8$K]1VJ">86J;[B_BB7.,N@']:Y
M3PM/+>^(-1N#,0\B;B2H.1NXX^F*QG549QAW,IU%&48]SM:*B\N?_GX'_?H?
MXT>7/_S\#_OT/\:V-26BHO+G_P"?@?\ ?H?XT>7/_P _ _[]#_&@"6BHO+G_
M .?@?]^A_C5#5M0.DV37$MR"QXC3ROOMZ?\ UZ4I**NQ-J*NS39@BLS'"J"2
M?05CV?BC3KR&9T<QO$I;9+A2V!GCGGI7)W?BS4KVTDMF6%%E&TF-3NQZ#FH=
M6T"?2K"UNG+-YH_>+M_U38X&>_?\J\^>+;UI*Z6YPSQ3>M-72W&6.OZAI\\D
MT+C;,^]D<;E/L,_6K=I:R:A8:QJMS&S_ +LB(MEL,3V^@XK?7P\+GPQ!9Q3H
M"RK*KO'G:3@G!SFM73M-.FV26\,RJ!RV(^K=SR:FGAIMI3>EOQ8H8>;:4GI;
M\6<3IFCWDVBZA<I;NWF1K'$H'+G>">/PJ_X2673]=FLIT*RRP!BI'*D<X/X&
MNQ\N?_GX'_?H?XUPOB3S[#7[B5V!^TVY5648R"-OX=*<Z*H*,UT_X(3I*BHS
M73_@G?T5Y[I'B6XL=,G@,RDQKFW#*6+,3R"?0=:ZK0=1N=7TW[3)(L;ARA"Q
MC!([CGWKJI8B%2R6YTTZ\*EDMS8HJ+RY_P#GX'_?H?XUC>(-9GT6"(HZRRRD
M[0T>% '4GFMIS4(\TMC64E!<S%\6:C]AT@Q(<2W.8Q[+_$?Z?C7,ZI8?9_"V
MDS>6@=RQ=@N&.[E0>YH.I/XCUK38KM%"AMC*HX.>>GX5VMWIB7T21W++(D;!
MD'EXP1]#7!R_6'*2>FR_,XN7V[DT]-E^9SK^%DN/#]O,D;)?+;@B-, .Q.?F
MSWQ6]H%G)8:);V\J%)1EG4]B35W9/_S\#_OT/\:/+G_Y^!_WZ'^-=4*$(2YE
MVL=,*,8/F7:Q+147ES_\_ _[]#_&CRY_^?@?]^A_C6YL2T5%Y<__ #\#_OT/
M\:/+G_Y^!_WZ'^- $M%1>7/_ ,_ _P"_0_QH\N?_ )^!_P!^A_C0!+147ES_
M //P/^_0_P :/+G_ .?@?]^A_C0!+147ES_\_ _[]#_&CRY_^?@?]^A_C0!+
M147ES_\ /P/^_0_QH\N?_GX'_?H?XT 2T0?\A2#_ *Y2?S2HO+G_ .?@?]^A
M_C3K59%U6'?*'_=28^3&.5H V**** "N%U6P\.M?RP>*O%'VIRV\6-S=K!$B
MGE?W:XSQW.<UW5>:^++0WGBB\AM+75+C?#$+U8([8J5YVA'E(93C/*_SH ]#
MM+FVO+2.>SFBFMW'R21,&4CV(J>LW0](BT:Q>")V82SR3ME0N"[9P . !TK2
MH **** ,O5_^/G3?^N[?^BGK-UK54T?3S<%0\A(6-"<;C_\ 6K2U?_CYTW_K
MNW_HIZXG6(Y]>\4C38WE%O!@/QPG'+?R%85YN$/=W>B,:TW&/N[O1',1W5S&
M9?*FD3SC^\",1OY[XJ2;4;V>W%O+=3/" !Y;,2..G%>A3>';.:YL9M\B_8U"
MHJX ;'(SQ7)7N@/IVMVL<Q5[:XN J?-DE<C.?SKRZF'JTUOI_7ZGG3H5(+?0
MO^!;C$UY;''*JX_ X_K78&X@60QM/$) ,E2X! ^E<'?7S^'_ !/=FPBB5 JQ
MA&7(VX!K*DAOM1\[4#&\Q:3:[*I)R1Z#M@5M#$>RC[-*[39K"O[*/(E=JYZF
MDB2H'C=70]&4Y!IU<AX.U6WBMAIDA99VE8Q@*2"",G/IT-=?7H4JBJ04D=U*
MHJD5)!1116IH%%%% !1110 45GZKK-IH\<;7)8F0X54&3CN?I4MYJ5K96/VN
M:51&R[H^?O\ &0!4<\=5?8GGCJK[%IF5%+,P55&22< "LQO$6F+=6]NEP)7G
M.%,7S*#G')[5R6H^)[K6+06*P+ 99 #L8G</0_CBDG\':K#+((ECE5"-C!P-
MWX'IBN.6*E+^"KHY)8B4OX2NC9\4ZQ&VEI#8W"2&:38QB;+#'.!CWQ3O#FN6
ML.A*+^]59(I"AWDEL'I[FL+3]%O;3Q#817EL^QI [%?F4#GJ1P.15.[T348;
M\PFTF9I';RR%SN&>N>U<[K55+VMO*VI@ZM52]I;RL/O(9-3_ +3UB,,L22@C
M/?)QU]1Q^=>C6,OGZ?;3<_/$K<]>E<XVE267@2Y@DW),5\Z16QP<CCCZ5@Z9
MXFO=,ADC_P!>K !/-<GR\#M_GM5TYJA*\_M*[];LN$U1E[_5?YGI%%8&C>(5
MN-$EO+]]K0/MD94P#GI@#K6S:W45[:QW,#%HI!E21C/X5Z$*D9I-,[H5(R2:
M)J**CGGBMH6FFD6.-1DECBM&[%[$E%<UI?BT:EJJV?V01I(2(WW\\ GD>M1^
M)?$=SIMY%;V1B^[ND+ -SGI[?_7KG>)I\G/?0P=>'+SWT.IKE?%^H75M<V4%
MG/(D@#2LL9Y..F?;@U'J/BV:.PL)+-(_.G0O(&&=N#@C'USS5;PU9G6=2NM3
MO6W[<KMR?O,/Y 5C5K*I^ZI[O_AS*I553]W#=_\ #F7!IVH>(6N[]#&[*2T@
MS@DXS@"K?A03V?B-;>6)HVDB8,L@((&,CC\*[BRL;;3K86]K'Y<8.<9R<_6L
M&^<P^/=/=E^62'8IS_O5E]7]GRS;UNK_ #,_8>SY9MZW5SIJ***],] ***R_
M$5[)8:)/-"Y24D(C#J"3_P#KJ9R48N3Z$RDHIR?0O7%Y:V>PW,\<6\X7>V-W
MTKS];ZY\1ZU:VUW)NMS,=L:@+A>_3V%5)KB_UM"TTBR_8X"Q+<';D9/N>:ZO
MPAIML-+AOF@4W)9]LA'('3BO.=26)FHK2._KL<#G*O-16B_,T8_#FFP:A%>P
MQ-')&<JJM\O3'0U8U/3(-6M!;W!D"!@WR-@Y%7:*]#V<$FK:,[O9QLU;1C8T
M6*-(T&U$ 50.P%.HHJRPKB/&:-)K=BBC+-& !ZDN:[>L/5=&FO==T^^C\MHH
M"/-5SV!SQZ__ %JY\3!SI\J[HPQ$'.%EY&#XCT;'B"V$;1JMZX4(B[=F, UL
M>#.-)GB[I<L/T%;DMG;7%Q!--"KR0MNC9NJGVKSJ'5I]-;4[500EP7!Z@J<G
M!'YUS34:%7VCV=_R_P SGFHT:G.^M_R_S._LM5LM0DF2VFWM"</D$8//KUZ&
ML3Q&1<Z_HUD%5F\S>P;I@D<$?0&N+GAGLC$"2 Z),F.AR.#^'(KJ-(DCUKQ>
M;TDD0PJPZC+  9_,FI6(=5>S:UNO\R57=5<C6MT7]/\ "S6&MB_%S&8E9F6(
M1D8!S@?AFNDHHKOA3C35HG="$8*T0HHHK0L**** "BBB@ HHHH **** "BBB
M@ HHHH *(/\ D*0?]<I/YI11!_R%(/\ KE)_-* -6BBB@ KR/QC!9+KER^HW
M-C/=1J@DW:*)GVD,V<^8,A4&3Z<=SBO7*\Z\7KJ(\2R/;Z/',6@2.$_V9]H%
MV,Y:.27(\M00/YT =^9EAM%DPSJ%&!&N2?3 JJ-9M3Y>!+ACASL/[H[MN&].
M01^%69TN)+0K;R)#.0,,R[POKQD9JA_8[L%5I8@KA5G"QGYMK%A@EN#DG).<
MT 6YM1@@NA ^_/ 9PORH3T!/;-0C6;=D)6.<OD;8_+.YP02"!W& ?RIDFER7
M$S/+(BQRLK31A222I^7!SQQC/':F)I$R-',+F,W$(5(F,1VA%##!&[DX8\Y%
M %+Q/J0M]+L]0M_G <M&<<<Q/C/YUSO@E9;B\O[R5I'9@%9C_$2<\^]:'CFW
M6Q\.:?#&-VR81 GT*-G^5:.FZ=#;Z;;1O&/,6)=Y&1DXKEE%SKK72*_,YFG*
MLNR1HX/H:RM6TF74;O3YDD5!:R^8P8$[AD<#\JO?9(/^>?\ X\?\:/LD'_//
M_P >/^-=$HJ2LS>45)69QNO:=)>>);U(X7=S:B1 JDY88X'OUKH_#-I-8Z'!
M%+"T,I9F=6ZY)[_ABK_V6#_GG_X\?\:/LD'_ #S_ /'C_C6,*"A-SZLRA149
MN?<\_AC?2_%D<DB/! +I@'D4@%<D=3UX->CX/H:Y;QE91#28[E RM#* !N."
M#5V75=)MM.M+R8/Y5P,(5#$YQSGGBLJ*5&4HMZ;F=)*E*46]-S<P?0T8/H:R
MEO-+?4DL$.^=T\Q=I)7&,]<^E7OLD'_//_QX_P"-=BDGL=2:>Q/@^AHP?0U!
M]D@_YY_^/'_&C[)!_P \_P#QX_XTQD^#Z&JFHZA;Z9:-<7+;5'"KW<^@]ZXO
M7-3N)]4DATSS5BM<[FA+'=CJ6]@>*IM=7/B"6QL%"B09#,6^^W]X^G%<,\7'
M6,5KT..>*6L8K7H6;RYN?%VJ)%:P!%BB8HK$9'KD^YP*C@\/:O/=VMK>0W*6
MY;[Q.Y8QW[X%;^C^&I-.UFYE?#6FTK#EOF;)'7'2N@^R0?\ //\ \>/^-1#"
M^T]ZK>]R(8?G]ZIN4[+P]IVGS)/;VY$R# =F)/3!]JT\'T-0?9(/^>?_ (\?
M\:/LD'_//_QX_P"-=\8QBK15CMC%15DB?YL=Z,'WJ#[)!_SS_P#'C_C1]D@_
MYY_^/'_&J*'7%O'=6\D$R%HI!M9>1D5FQ^%M'C<,+('M\SL?ZUH?9(/^>?\
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M]G_"IJ* (<W/]R'_ +[/^%&;G^Y#_P!]G_"IJ* (<W/]R'_OL_X49N?[D/\
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M;G^Y#_WV?\*FHH AS<_W(?\ OL_X4^T,IU6'S%0#RI,;6)[K[4^B#_D*0?\
M7*3^:4 :M%%% !1110 4457EO8(;A(&+F1AD!(V; SC)(''XT 6**KR7UM%<
MK;O+B5L8&#CG.,GH,X/6HAJ]B8FD$Q*J0,!&R<],#&2.#R/2@"#5_P#CYTW_
M *[M_P"BGI*34Y$EDTN2-@R/,S*PZ$&)Z6@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *(/^0I!_P!<I/YI11!_R%(/^N4G\TH U:*** "B
MBB@ K-O=.>XO4GC6%6 4>=R)$ .<#L0<D=NIZUI44 9$NG7%U/(6"1PSNCR
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M@>U %35_^/G3?^N[?^BGI*K:CJ%O+'H]T\B1)+*6'F.!C]T]']HV/_/]:_\
M?Y?\: +-%5O[1L/^?ZU_[_+_ (T?VC8?\_UK_P!_E_QH LT56_M&Q_Y_K7_O
M\O\ C1_:-A_S_6O_ '^7_&@"S15;^T;#_G^M?^_R_P"-']HV/_/]:_\ ?Y?\
M: +-%5O[1L/^?ZU_[_+_ (T?VC8?\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\
MC1_:-A_S_6O_ '^7_&@"S15;^T;#_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-
M%5O[1L/^?ZU_[_+_ (T?VC8?\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:
M-A_S_6O_ '^7_&@"S15;^T;#_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[
M1L/^?ZU_[_+_ (T?VC8?\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-A_S
M_6O_ '^7_&@"S15;^T;#_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L/^
M?ZU_[_+_ (T?VC8?\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-A_S_6O_
M '^7_&@"S15;^T;#_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L/^?ZU_
M[_+_ (T?VC8?\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-A_S_6O_ '^7
M_&@"S15;^T;#_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L/^?ZU_[_+_
M (T?VC8?\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-A_S_6O_ '^7_&@"
MS15;^T;#_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L/^?ZU_[_+_ (T?
MVC8?\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-A_S_6O_ '^7_&@"S15;
M^T;#_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L/^?ZU_[_+_ (T?VC8?
M\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-A_S_6O_ '^7_&@"S15;^T;#
M_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L/^?ZU_[_+_ (T?VC8?\_UK
M_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-A_S_6O_ '^7_&@"S15;^T;#_G^M
M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L/^?ZU_[_+_ (T?VC8?\_UK_P!_
ME_QH LT0?\A2#_KE)_-*K?VC8_\ /]:_]_E_QJ2RNK>XU6$07$,I$4A(CD#8
MY3TH VJ*** "BBB@ HHHH *@NK5;I%!>2-T;<DD9PRG&./P)%3T4 <K(;Z*X
M>T>2**"W$CV[QRQ;B>!&A#\C@MG^=:&IO?V^F6L]NEH]P!^^4LJHY\ML;2W;
M?M/4<"HM372[6^D9-,2YOYO+>4+:M)\F[:6.%.#MW8]=N.U7M5CTZ31WDU"W
M$EI"HF*LG*;>00.H(H K:,DGF2(\D<L C1ADQEE<Y+ ;.-HX'/?/:LZXEU W
M4Z2201& 2M!(DD/SL7.Q6#<@!-N>G0\FM;1I[*8W/V1;%</Q]E93N3^$MCH>
MO%9FHW&BV-]*W]G1M<S3*9S+;-AESAG!VX)QZ=<4 :6J-=V]E!-;);-*K9E5
MF55<;&X!;_:VGMP.M0Z(LYD*RR12Q&%7=28R4E/+*NS^$>_?O5K6VTQ=&EDU
M2+S+- '*^67(QR" !G/TJ'1KJSFNKJ.UM(X@I!62* H&3 QDD#YL[N/09[T
M9>H2:BFI-&'0Q@R-&\3P+Y9X"!M_.,9S@$Y]N*T]4^VPZ7!);M;"X S)]T!S
ML. N[C&['?.,\U!J2Z7:7\C)I:7-[,8GG"VK2?)NVECA2 <!L=SMQVJ_JT>G
M/I+2ZC;K):0@3;63)3;R"!U!% %/P_Y\BR>=CR@B;8Y&B9T?G=_J_EV],=^#
M6;>RZFNH21B2/Y=YAD22!51BV%5PWS;=N,X&<[N>1C;T::SF%S]E6Q7$F/\
M164Y3^$MCH3SQ67J%SHEC?R'^S8S<33J;@RVK<CH7'RX)X[=: -351<Q6$<E
ML8$E5@7SM&[Y3P-W'WL?AGD'FJ?AXW4N[[1M\ORU)C=HF99#G=CR^ OIGFKN
MNMIBZ1))JL7F6B8<CRRY!'(( &<_2HM%NK.>XNDM;2.(*P*O% 4#)VR2!\V=
MW'^- %?9=Q2S/)J6G&03.8XIXU(1<G: 05(^7&<YJYJ44Y^R-!=P6D8<F9V5
M2&&TX !]\=Q]:I:BNEVE_(8]+2YO9FCDN MJTF$)P6.%(!P&QW.VM#5X].;2
MVEU*W62U@VRX9,[".A [8_EF@ TU697226QF5,!#;)MP/<9.*ST6[B9FEU/3
M6F$DF(YHU.Q2YP RD$?+C.0>1UJ]HTUG,EQ]E6R7$A&+5E.4R=I;'0D=JR;Z
MYT2QOWQIL9GFG!N#+:MR.A<97!/ Z=: -?4XI2ML;>ZBM%$N9I&53E=C8 W#
M^]M]. >:--#'S$>:PG1<;?LT>W'KD9-)KS:8FE/)JT7F6L;!\>67(8'@@ $Y
MJ+1;JTGFNDMK2.$*W#Q0E%9.V20/FZ\=N/6@#+U!]06[DVS1@JTFS8\ "G/[
MO[W.W'W^^<8XS6IJOVN*S@:![>-_^6A^5<G'&-W&,]>^,XYJKJ*Z5::A)Y6E
MI<WDKQR7(6U:3"$XW'"D9P#]<5HZPFFG33-J4"26T#++\R9V$'@^V/Y9H JZ
M +ATE%P8WC54"C,;%6YW8V<!.FT'GKFLR[?4Q=/B> .I<1['A"JV?ESN^;9C
M&X?>STXK;T::TECG^RK9*1(01:LI!7)V%L=R.U9-Y<Z)8Z@0NFQ^=-<;K@R6
MK#C!!=<KR20.G7K0!JZN)XK:-K=HH_G_ 'A^56(P<;2W'7&<]LXYJKH N7\U
M;EHGC5%X!C.'YW;=G1.F >>N:MZ\VF1Z8TFK1"2V1U;'E%R&!X( !.:CT2ZM
M9Y+I;:TCA"OPT4)167G;DD#YNN1VR/6@#(OO[2>^8QW:021/)M&^#RF7G8,$
M%P<[=W3HV.U:VKFXBM[<Q;45CB8PM&LG3C89/EZ]<]JJWXTJTU&00Z6ES=RR
M))=!;5I-JG(W'"D;L#IWQ6CK*:;_ &?Y^IP));P.L@+)G8<X!]NO/MGM0!4\
M.Q7:VS1WEQ#<A%0*PV%@<'(^0 8Z8XZY[8K+N/[4>^WI=Q0RQ&0;2\'DOS\@
M P7 X&[..^.<5O:/+:2Q3?95LE(D8$6K*1MR=A..Y7!K(N;G1++4-B:;&)IK
MC=<&2U8=B"ZY7DD@=.N2: -363-#;Q-;A40OB4H463;@XV%_ESG'7MFJWAV*
M[6&2.[N(;E%5=I_=EE.3D'8 ,8V_CN[8JWKS:7'IOFZM")+=)%8#RC(0^>"
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MP<"MZPTRUTQ72T5XXF);R_,9E!))) )XR3VJY0!E:G*D>C):F*<O=J+:.-)
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ D$# 2(  A$! Q$!_\0
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MHH **** *&I74]N]HD!C!FE*$NI; ",W3(_NU%]HOO\ GM!_WY/_ ,51J_\
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M_P#Q5'VB^_Y[0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\
M%4E% "_:+[_GM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q
M5'VB^_Y[0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E%
M "_:+[_GM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB
M^_Y[0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:
M+[_GM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[
M0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_G
MM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\
M?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_W
MY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__
M !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\
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M'J*,CU%1?9K?_GA%_P!\"C[-;_\ /"+_ +X% $N1ZBC(]147V:W_ .>$7_?
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M_P#GA%_WP*/LUO\ \\(O^^!0!+D>HHR/45%]FM_^>$7_ 'P*/LUO_P \(O\
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MT/)->G0?\A2#_KE)_-*X<*_:2E5>^QQX=^TE*H_0U:***[CL"BBB@!"0 22
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MVT.BVYF8-&Y4E<8)\I_45-Y+_P#/S+_X[_A4VK_\?.F_]=V_]%/24 1>2_\
MS\R_^._X4>2__/S+_P"._P"%2T4 1>2__/S+_P"._P"%'DO_ ,_,O_CO^%2T
M4 1>2_\ S\R_^._X4>2__/S+_P"._P"%2T4 1>2__/S+_P"._P"%'DO_ ,_,
MO_CO^%2T4 1>2_\ S\R_^._X4>2__/S+_P"._P"%2T4 1>2__/S+_P"._P"%
M'DO_ ,_,O_CO^%2T4 1>2_\ S\R_^._X4>2__/S+_P"._P"%2T4 1>2__/S+
M_P"._P"%'DO_ ,_,O_CO^%2T4 1>2_\ S\R_^._X4>2__/S+_P"._P"%2T4
M1>2__/S+_P"._P"%'DO_ ,_,O_CO^%2T4 1>2_\ S\R_^._X4>2__/S+_P".
M_P"%2T4 1>2__/S+_P"._P"%'DO_ ,_,O_CO^%2T4 1>2_\ S\R_^._X4>2_
M_/S+_P"._P"%2T4 1>2__/S+_P"._P"%'DO_ ,_,O_CO^%2T4 1>2_\ S\R_
M^._X4>2__/S+_P"._P"%2T4 1>2__/S+_P"._P"%'DO_ ,_,O_CO^%2T4 1>
M2_\ S\R_^._X4>2__/S+_P"._P"%2T4 1>2__/S+_P"._P"%'DO_ ,_,O_CO
M^%2T4 1>2_\ S\R_^._X4>2__/S+_P"._P"%2T4 1>2__/S+_P"._P"%'DO_
M ,_,O_CO^%2T4 1>2_\ S\R_^._X4>2__/S+_P"._P"%2T4 1>2__/S+_P".
M_P"%'DO_ ,_,O_CO^%2T4 1>2_\ S\R_^._X4>2__/S+_P"._P"%2T4 1>2_
M_/S+_P"._P"%'DO_ ,_,O_CO^%2T4 1>2_\ S\R_^._X5$KQM+Y2ZAF3.-@=
M,_EBK+.L2-(YPJ LQ] *\D$^VZDG0'+%\'."-V><^O-<N(Q'L;:7N<]>O[*V
MFYZOY$F<?:)OR7_"D:-E!+74B@=2=H'\J\UNM7N)K"SM4GE"PI\XW?>;<<'U
MZ&M'Q#KD&L65E!;K+YJG=(N.-V,8]ZS^NPLW;;\3/ZW&S9I^)4BN-1TFW:X\
MY6G*R)N4X!*^G]:Z80,H"BXE '  "\?I7!>%]'?4-0%TQVQ6SJS97.]O3->A
MU>&;GS5&K7+P[<[S:M<B\E_^?F7_ ,=_PJ"\@<V-P/M$I_=-Q\OH?:KE1W S
M:S#UC;^5=3V9T/8YOPA;+-H(9F/$[$#:IP>.1D&NC\E_^?F7_P =_P *P_!7
M_(O_ /;9_P"E=#6.'_A1]#*A_#CZ$7DO_P _,O\ X[_A574[>1]*NU$\I)A?
M@[>>/I5^HKG_ (])_P#KFW\C6LE=-&LE=-'$>"49]0N2K.@\D?,H'J..17;^
M2_\ S\R_^._X5SW@90-%F8 9,W)]<**Z:N?"1M11AAE:DB+R7_Y^9?\ QW_"
MG6B,FJPYE=\Q2?>QQROH*?1!_P A2#_KE)_-*ZCH-6BBB@ KR3Q<+76]6NW&
MDH%($+7,V@W,LZ[>"5<$*1Z<8KUNO*?$]KIFMZ]/)>ZE/I-V2L,2:G!(L049
M#%&#!#GAASUSD$'  /4D*QVZDL JJ.3QQC]*4RQ@H#(N7^Z,_>^GK5>[C#6&
MP0_:  ORKMYQW /''7%8R:9<K%'$;9B2$6*0[<PA9"V6YX)!'W>,C% '1&1!
M((RZAV&0I/)_"F^?"$9_-CV*<,VX8!]#6-<6LUW>M)' V9'1HYV 'DA"0PZY
MYYZ?WJ@BT^9&BE;3V\J)426 !"96"N"^,X/+#KSQ0!H:O_Q\:;_UW;_T4])5
M2YMIX+?1(6E"O&Y5OEW<^4]3>7/_ ,_ _P"_0_QH EHJ+RY_^?@?]^A_C1Y<
M_P#S\#_OT/\ &@"6BHO+G_Y^!_WZ'^-'ES_\_ _[]#_&@"6BHO+G_P"?@?\
M?H?XT>7/_P _ _[]#_&@"6BHO+G_ .?@?]^A_C1Y<_\ S\#_ +]#_&@"6BHO
M+G_Y^!_WZ'^-'ES_ //P/^_0_P : ):*B\N?_GX'_?H?XT>7/_S\#_OT/\:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$<$+C[QS^5=,ZL(.TG8Z)U80=I,Z?%S_ 'H/^^6_QKF/%D,EW=:79OL+RR$
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M/%=,:R]GSST.B-5<G/+0W:*Q-!UN;5[1F,< GC;#J'(^A P:UMUQ_P \HO\
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MN/\ GE%_W\/^%&ZX_P">47_?P_X4 2T5%NN/^>47_?P_X4;KC_GE%_W\/^%
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MD?XT 345#YY_Y]Y_^^1_C1YY_P"?>?\ [Y'^- $U%0^>?^?>?_OD?XT>>?\
MGWG_ .^1_C0!-14/GG_GWG_[Y'^-'GG_ )]Y_P#OD?XT 345#YY_Y]Y_^^1_
MC1YY_P"?>?\ [Y'^- $U%0^>?^?>?_OD?XT>>?\ GWG_ .^1_C0!-14/GG_G
MWG_[Y'^-'GG_ )]Y_P#OD?XT 345#YY_Y]Y_^^1_C1YY_P"?>?\ [Y'^- $U
M%0^>?^?>?_OD?XT>>?\ GWG_ .^1_C0!-14/GG_GWG_[Y'^-'GG_ )]Y_P#O
MD?XT 345#YY_Y]Y_^^1_C1YY_P"?>?\ [Y'^- $U%0^>?^?>?_OD?XT>>?\
MGWG_ .^1_C0!-14/GG_GWG_[Y'^-'GG_ )]Y_P#OD?XT 345#YY_Y]Y_^^1_
MC1YY_P"?>?\ [Y'^- $U%0^>?^?>?_OD?XT>>?\ GWG_ .^1_C0!-14/GG_G
MWG_[Y'^-'GG_ )]Y_P#OD?XT 345#YY_Y]Y_^^1_C1YY_P"?>?\ [Y'^- $U
M%0^>?^?>?_OD?XT>>?\ GWG_ .^1_C0!-14/GG_GWG_[Y'^-'GG_ )]Y_P#O
MD?XT 345#YY_Y]Y_^^1_C1YY_P"?>?\ [Y'^- $U%0^>?^?>?_OD?XT>>?\
MGWG_ .^1_C0!-14/GG_GWG_[Y'^-'GG_ )]Y_P#OD?XT 345#YY_Y]Y_^^1_
MC1YY_P"?>?\ [Y'^- $U%0^>?^?>?_OD?XT>>?\ GWG_ .^1_C0!-14/GG_G
MWG_[Y'^-'GG_ )]Y_P#OD?XT 345#YY_Y]Y_^^1_C1YY_P"?>?\ [Y'^- $U
M%0^>?^?>?_OD?XT>>?\ GWG_ .^1_C0!-14/GG_GWG_[Y'^-'GG_ )]Y_P#O
MD?XT 345#YY_Y]Y_^^1_C1YY_P"?>?\ [Y'^- $U%0^>?^?>?_OD?XT>>?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M: +-%5O[1L?^?ZU_[_+_ (T?VC8_\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\
MC1_:-C_S_6O_ '^7_&@"S15;^T;'_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-
M%5O[1L?^?ZU_[_+_ (T?VC8_\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:
M-C_S_6O_ '^7_&@"S15;^T;'_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[
M1L?^?ZU_[_+_ (T?VC8_\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S
M_6O_ '^7_&@"S15;^T;'_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L?^
M?ZU_[_+_ (T?VC8_\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S_6O_
M '^7_&@"S15;^T;'_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L?^?ZU_
M[_+_ (T?VC8_\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S_6O_ '^7
M_&@"S15;^T;'_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L?^?ZU_[_+_
M (T?VC8_\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S_6O_ '^7_&@"
MS15;^T;'_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L?^?ZU_[_+_ (T?
MVC8_\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S_6O_ '^7_&@"S15;
M^T;'_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L?^?ZU_[_+_ (T?VC8_
M\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S_6O_ '^7_&@"S15;^T;'
M_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L?^?ZU_[_+_ (T?VC8_\_UK
M_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S_6O_ '^7_&@"S15;^T;'_G^M
M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L?^?ZU_[_+_ (T?VC8_\_UK_P!_
ME_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S_6O_ '^7_&@"S1!_R%(/^N4G\TJM
M_:-C_P _UK_W^7_&I+*ZM[C581!<0RD12$B-PV.4]* -JBBB@ HHHH ****
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MGZ;;:7"8;0.D.<K&7+*G^[D\=>E6Z ,O79 UDMBJRM->$Q1B-PAS@L26/0
M]CGI@U!HOV@:C>+?NYOO+C+ ;?+\O+[2N.^=P.>>!VQ6I=V=O?1"*XC#J&#+
MR05(Z$$<@^XIMI86UB'%O&5,AR[LQ9F/NQ))_.@#B?%!6YUN5[:YMQ,$$*[&
MC#%ANP'W'LV./1B>HKJ-?F*:*T0O8;2YFVK$78X=L@E1M^8Y (^7GGBK][9Q
M7]J]M,7\I^'",5W#N"1V/0U2U^]T72M(:[UQX(K"$J"\RY"$\#'&0>>U &=X
M6-W(\\Z&(:9+@PJ/-&".I&_G!/TZ?4U7\0:=?W!DEN4ADMG(3R8$#2.,\ $Q
MD@GUR /4=:O>%-2\.ZAILDGAS4([FRC;:524L(CUQAN5]<5J_P!IV)U7^RQ=
M1&^\G[1]GW?/Y><;L>F>* *NO2![-;!5E:>\8QQB-PA&!N)+'H !Z'/3!J'1
M?/%_?+?.YOMD1<<>7L^;:5QZD,#GG@=L5IW5I;7\(2=!(@;<I#$%2.X(Y!]Q
M26EA;6*N+>/:7.YV9BS,?=B23^- '$>)2+G7)I+6YMA-M6)=C1ABPW8#[CGA
ML#Z,3U%=;KLWE:+< 7T5E-(A2*9VP Y' &.3^'/I5N]LXK^U>VG+^4_#JK%=
MP[@X['H:=/:V]U#Y5Q#'+'_==010!SGAC[:]U/-'Y(TX@)M'G#$BE@Q7S.3S
M@'H..]1:]IU_.[RW20R6[NJ^3;H&D?G@!C&2#QUR /45T5AIEKIB/':*\<3$
MMY9<LJDDDD GC)/:KE &3KTF^U2P19&N+MML8C<)C;\Q))SQQR,'/3%1:)YP
MOK];UW-_B,R+QY>SYMI7'KALYYX],5J7=E;WT:QW$>\*VY2"5*GU!'(/TI+2
MQMK%'6WCV[SN=F8LS'U+$DG\: .&\1,+G7II+2YMO-PL2"-HP2PSC?N.>&X.
M.@;(Y%==K\WE:-<*M]'93RKLAE=B/G/0#')_#GTJW>V<5_;-;3E_*?AU5BNX
M=U..Q[BGW%K;W<7E7$,<J==KJ",^M '.>%S>/<SS1^2--8!%4>:,.I8,5\SG
MDX!Z#Y>_-0ZYIVH3RF:ZCAE@>1%$-NH:1L'(PQC)!XSG<,>HKHK#3+73(VCM
M%>.)CGRRY95)))P">,D]JN4 9.O2>9;QZ?&LC7%TW[L(X3&W#$DD'C@9&#G.
M,5%H?FB\OUO'D-^/+,J\; N#M*X]<'.>>/3%:=W96]]&J7$>X*VY2&*LI]01
MR#]*+2QMK%&6WCV[VW.Q8LS'U+')/XT <-K["X\032VES;>:=L:"-H\LPZ;]
MQSPP(..@((R<UUOB";R]&G1+Z.SGE&R&21B,MZ#')S[<^E7+VRBU"V-O/O\
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MR2SSIY0TR0 1*OFC##(8KYG/)Z\ <=^34/B+3]0N!-+<)!):M^[\F% TD@[
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M/IZ4 8'A8W<CSSIY0TR3'DJ!*,$=2/,YP3].GU-5_$&G7]QYLMRD,ELY">3
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1** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ D$# 2(  A$! Q$!_\0
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MV@_[\G_XJC[1??\ /:#_ +\G_P"*I** %^T7W_/:#_OR?_BJ/M%]_P ]H/\
MOR?_ (JDHH 7[1??\]H/^_)_^*H^T7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[
M\G_XJC[1??\ /:#_ +\G_P"*I** %^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_
M (JDHH 7[1??\]H/^_)_^*H^T7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[\G_X
MJC[1??\ /:#_ +\G_P"*I** %^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_ (JD
MHH 7[1??\]H/^_)_^*H^T7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[\G_XJC[1
M??\ /:#_ +\G_P"*I** %^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_ (JDHH 7
M[1??\]H/^_)_^*H^T7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[\G_XJC[1??\
M/:#_ +\G_P"*I** %^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_ (JDHH 7[1??
M\]H/^_)_^*H^T7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[\G_XJC[1??\ /:#_
M +\G_P"*I** %^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_ (JDHH 7[1??\]H/
M^_)_^*H^T7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[\G_XJC[1??\ /:#_ +\G
M_P"*I** %^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_ (JDHH 7[1??\]H/^_)_
M^*H^T7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[\G_XJC[1??\ /:#_ +\G_P"*
MI** %^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_ (JDHH 7[1??\]H/^_)_^*H^
MT7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[\G_XJC[1??\ /:#_ +\G_P"*I**
M%^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_ (JDHH 7[1??\]H/^_)_^*I]M=7)
MO4AF>)D=&;Y8RI!!'N?6HZ(/^0I!_P!<I/YI0!JT444 %%%% !1110 5%<_\
M>DW^XW\JEJ*Y_P"/2;_<;^5 &/I__(,L_P#KA'_Z"*L57T__ )!EG_UPC_\
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M=><FWLSB]-T.&U\8_8VF>1;9!.K8QN/&,^W-.\5VK7?B2WB'R^9!PWJ1N/\
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M5+10!%FY_NP_]]'_  HS<_W8?^^C_A4M% $6;G^[#_WT?\*,W/\ =A_[Z/\
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M.L[P5>RIJ3V6YC#(C/M[!ACG\JEXBU=03T?YB=>U91Z/\SMLW/\ =A_[Z/\
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M_7!_Y5E6@ITVF9UH*<&F<#8H-1U'2K1T$L21[63)P 2Q.<=.HKT0?:0  L.
M,?>;_"N-\"Q$ZA=RX&%B"_B3_P#6KN*PP4?W?-W_ $T,<(O<YNY%FY_NP_\
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M_P#'I-_N-_*A;F!R@6:-C(,H P.X>H]:9-+'+:3F.17"JRG:<X..E &5I_\
MR#+/_KA'_P"@BK%5]/\ ^099_P#7"/\ ]!%6* "BBB@ HHHH **** "BBB@
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M[HJQY<W_ #\_^0Q3-/\ ^099_P#7"/\ ]!%6* (O+F_Y^?\ R&*/+F_Y^?\
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MMX!/M\N, CRUX..:N(B1KMC14'HHP*=10PZI:WNQT:"I:WU(3'/@_P"D=O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO_/2;_OZU'V=?^>DW_?UJEHH B^SK_STF_[^M1]G7_GI-_W]:I:* (OLZ_\
M/2;_ +^M1]G7_GI-_P!_6J6B@"+[.O\ STF_[^M1]G7_ )Z3?]_6J6B@"+[.
MO_/2;_OZU'V=?^>DW_?UJEHH B^SK_STF_[^M1]G7_GI-_W]:I:* (OLZ_\
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MZY2?S2@#5HHHH **** "BBB@ J*Y_P"/2;_<;^52U%<_\>DW^XW\J ,?3_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7_&C^T;'_G^M?^_R_P"- %FBJW]HV/\ S_6O_?Y?\:/[1L?^?ZU_[_+_ (T
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MK7_O\O\ C0!9HJM_:-C_ ,_UK_W^7_&C^T;'_G^M?^_R_P"- %FBJW]HV/\
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MN&6"+=!=>5(BR$AE;)("L-N"#_M'%3:K-8Z=)++((A<7D3(JS-MBE9!E0Q/
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M_P")S!-:QR-Y\\<,(4)V4Y^8?-@9&0?4=*W= CM?)N+F P^9/+F98)O,12
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MN55B XC90S[2-P #8)+ >HH VZ*** "BBB@ HHHH *Q?%+P?V+)!-) GG,H
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MA!$8W':I(()QZX)&?0U%?Z1I^IJ5O+2.7(QN(PV/]X<T 5-$35(M%"79B:Y
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MBKS[.XMF:6Z1@(GCVL 4Y;)W$E0PX[JN.M=1XEFVZ8($O8K:>61=BR%OWH#
ML@"_,<C(^7UK1N[*&]$2S[RD<@DV!B Q!R,^N#@_44MU96MZ@2ZMXY@.F]<X
M^A[4 8OA7[8T,TS&/^SYB)+51Y@*J5'3?SM/)[=>E4M7T[4);N.>\CAEA>>/
M$-LH+D@@@AC'D8QDDL.G45TEA80:;;"VMMZPK@(C.6" #  ST'M5J@#)UV1I
M(X=/@21KJX;?'M<*%\LJQ+$@\9V@C!SG'K4>A&3[1J"W4DAOA(GGJ<;!\ORE
M,=B/7GCZ5I7=C;7R(MQ'NV-N1@Q5E/J&&"/PHM+*WL8V2WCVAFW,22S,?4D\
MD_6@#AM887'B22:SN;<R.Z*@C:,;B-N-^XYZAP<=!MQGFNL\13;-(DB2]BM)
MY2%A:1B-S9!VC;\QR 1\O//%7+VRAU"#R+C>8MP+*K$!L=CCJ/:GW-I;WD8C
MN8(Y5!R Z@X/J/0T <_X6-W(\\Z>4-,DQY*@2C!'4CS.<$_3I]35?Q!IU_<>
M;+<I#);.0GDP(&D<9X )C)!/KD >HZUT>GZ;;:7"8+0.D/\ #&7+*G^[D\#V
MJW0!E:]('LUL%65I[QC'&(W"'@;B2QZ  >ASTP:AT7[0-0O5OW<WVR(N/E\O
M9\VTKCWW YYX';%:EW9V]]$([B/>H8,IR05([@CD'W%-M+"VL5<6\>TN=SLS
M%F8^[$DG\: +-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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=44 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ D$# 2(  A$! Q$!_\0
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M_P#Q5'VB^_Y[0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\
M%4E% "_:+[_GM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q
M5'VB^_Y[0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E%
M "_:+[_GM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB
M^_Y[0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:
M+[_GM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[
M0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_G
MM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\
M?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_W
MY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__
M !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\
M\51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !5)
M10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\ \51]
MHOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !5)10 O
MVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\ \51]HOO^
M>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !5)10 OVB^_
MY[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\ \51]HOO^>T'_
M 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !5)10 OVB^_Y[0?
M]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\ \51]HOO^>T'_ 'Y/
M_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !5)10 OVB^_Y[0?]^3_
M /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\ \53[:ZN3>I#,\3(Z,WRQ
ME2""/<^M1T0?\A2#_KE)_-* -6BBB@ HHHH **K7\L4-G))-<_9HQC=+D#'/
MJ?7I6(+BX$ML[WWFQ\;8XYL2/F0@=!AL#&>>QH Z2N>TC_D#V?\ UR6I])NI
MY;A@9VG)@#RH6!\J7)^0>G?@^E4M)DF_L>S_ -')_=+_ ,M%H TJ*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):*B\R;_GV
M/_?Q:/,F_P"?8_\ ?Q: ):*B\R;_ )]C_P!_%H\R;_GV/_?Q: ):(/\ D*0?
M]<I/YI47F3?\^Q_[^+3K5G;58=\13]U)CY@<\KZ4 ;%%%% !1110 A4,,, 1
MZ&D"(,851CI@=*=10 @ &< #/)KG](_Y ]G_ -<EKH:Y[2/^0/9_]<EH N44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^^E_QH EHJ+SI/\ GVD_[Z7_ !H\Z3_GVD_[Z7_&@"6BHO.D_P"?:3_OI?\
M&CSI/^?:3_OI?\: ):*B\Z3_ )]I/^^E_P :/.D_Y]I/^^E_QH EHJ+SI/\
MGVD_[Z7_ !H\Z3_GVD_[Z7_&@"6BHO.D_P"?:3_OI?\ &CSI/^?:3_OI?\:
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MQ"YIJ/9-_H<M9<TDNR;&^!K=UAN[G<OEN1&!WR.?ZUUU<]X,0+H&[^_,Q_+
M_I70UIAE:E$O#JU*(40?\A2#_KE)_-**(/\ D*0?]<I/YI70;FK1110 5Y)X
MN%KK>K7;C24"D"%KF;0;F6==O!*N"%(].,5ZW7E/B>UTS6]>GDO=2GTF[)6&
M)-3@D6(*,ABC!@ASPPYZYR"#@ 'J<0 A0#IM';%/J)A(+7; R>8% 5F'R_7
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MNJ:O-J<%I#(J@6\>U2.K' !)_*NTM-->S\'S6=Q$/-,4C.@.[+'..GX5R_\
M9;VOA*>\F7$D\T:JI7!4 G.<],FO,G1G%>JNSSITI17JKLBUS6VU3RH555MH
M.$ZY;@#)JM=:;=V%O!<,&\JXB#"1,X^;^$GUQVKJ/"^@V<EG;ZE*LC3[F(5L
M;.XZ8Y%;6LZ0FKV"VIE, 1@RE5R/3&*T6&G4BZDGJ]C18>=2+G)ZO8Y[P?H]
MS%=_VA/&8X_*_=9_CW=Q^'\Z[.HK>!;:UB@3[L2!!^ J6O0HTE2ARH[J5-4X
M\J"BBBMC4*(/^0I!_P!<I/YI11!_R%(/^N4G\TH U:*** "O(_&,%DNN7+ZC
M<V,]U&J"3=HHF?:0S9SY@R%09/IQW.*]<KSKQ>NHCQ+(]OH\<Q:!(X3_ &9]
MH%V,Y:.27(\M00/YT >A18\E-I!&T8(&*?2+G8,@ XY [4M !7F/@W2(KJ63
M49MQ\B8B(#H6YR3].*].KG='4+HUH% &8@>!CFLITE.46^AG.FI23?0NT445
MJ:!6++H<DWBB/5FEC\I% $>#NR!@&MJBHE!2M?H3*"E:YS/C@,=)MR!\HGY/
MI\II_@N82:+)&22T<Q!R<\$#%;UQ:V]Y&(KF%)8\@[7&1D5S7A9C'K.LV^PH
M!)N"D8Q\Q'\JYI1<<0I]]/P.>47&NI=]/P.JHJ"*]MI[F6WBF1YH?]8@ZK]:
MGKK33V.E-/8****8PJC<:QIUK<+!+=QB5FV; <D'WQT_&HO$%Y+8:'<3PY$F
M H8?PY.,UYU)9WTD#W\L,QC8Y:9AU)[Y_K7'B,0Z;Y8J[.6O7=-VBKLZ[Q)X
MFN-/O3968170 R2,,]1T [57T71XM8\+/&Q$<C7+,LNW)7&/TJGHUK/KMSJL
MY"*TL.S>W(5CCI^ -=/X;T^YTW2?L]TJK)YC-A6SP<5C34JU3FEK%W,J:E5G
MS2^%W(- \.C2&G>=XIY7(",%^ZH^O>B+P[Y'B?\ M2*2,0<MY6W!#$8X[>];
MU%=BH022MMJ=2HP22ML9VJ:)9:N4:Z1MZ<!T;!QZ'U%1V'AW3M-N&GMXW+E"
MGSON !ZUJT57LH.7-;4KV<.;FMJ<1XMTJ#3W@U"U'E%I I10 JD#((].E90M
MKBP@LM;F+%9IRQ5>"0#G.??FO2)H(KB/RYHDD3KM=016'XPMQ)X=9E51Y+JP
MXZ#IQ^=<5?#)<U1>OS.2MATN::_IF^K;T5\8W ''IFEK*BUVQ&C"],R$1QC>
MBM\V[ RH]3S5VQO([^RBNH<A)!D!NH]C7=&<9:)G7&<7HF6****LL**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **HWVKVFG7%O!<,_F3G
M"!5SWQD_C5ZDI)MI=!)INR"BBBF,**** "BJ>J:C'I>GR7<JLP7 "KU)/2LO
MPKJ]WJL%T;LJS1N-I5<<$=/TK-U8J:AU9FZD5-0ZLZ"BBFM(B;=[JNXX&XXR
M?05H:#J*7!'4&N?\3:U)IL44-G,HO'<?*5#?+SSS[U%2:A'FD1.:A'F9MK<0
MO,\2S1F1.70,,K]1VKE=-D75?&]S>1_-# A"L#CMM'USS7.W6G:N;N22:RN!
M-,2[;(SSS[5V?A33&T_2O,EC*3SG<P;J .@]JXHU)5IJ+C9)W_R.2-25::35
MDM?\C=JIJ=@NJ:?+:22,BR8^8#)&#FK=%=[2:LSM:35F0VENMI9PVRG*Q($!
M(QG%3444)65D"5M HHHIC"BBB@ H@_Y"D'_7*3^:440?\A2#_KE)_-* -6BB
MB@ KQF_;0?LVKSRZ5I8U>/4FCBTUY9?/F3?@\!N6;)8$#&#7LU1&UMVN!<&"
M(S 8$A0;A^/6@!\?$:C;MX''I3J9,TBPL845Y,?*K-@$_6L==6NGMX)PL040
M02S+M)W>8<84YXQ@]<T ;=<]I'_('L_^N2U=L-0GGE G5-DL N$V(05&?NGD
MY/3ICOQ69I-S&-'LQB3_ %2_\LV_PH TJ*A^TQ^DG_?IO\*/M,?I)_WZ;_"@
M":BH?M,?I)_WZ;_"C[3'Z2?]^F_PH FKE;>X6U\?W439 N4"CW; (_D:Z3[3
M'Z2?]^F_PKC/%BM!K%OJ2,<':%4JRD%>>I'O7+B6XQ4UT:.?$-QBI+HR"SU6
M1-:UB[@W(\D,K)D X*D$9'X5J:+XJ#1P6^H,SSS2%5D50 HX W?C7*202Q6,
M-W\ZBX+J3R <$=^__P!:JT;F.19%P2C!AGIP:\R->=-K^M]3SHUYP:_K?4]@
MHK(T/5GU#2H[BYYF9F#>7$<<'CI2GQ#I\L=V()C(\$;,V(VQQ^'K7LJI%Q4K
M[GK*I&R=]S(\4:]87&FSZ?!*996*G<@RG!SUKH5LXKC1XK.=2T;0JC ''85Y
MK8:9<ZBS>3&6VL-X Z ]Z]0%Q&JA1YI &.8F_P *Y<-*55RG-:/0YL/*51N<
MEN9N@:(=%CN%:<2F5P1M&  .GX\UL5#]IC])/^_3?X4?:8_23_OTW^%=D(*$
M>6.QU1BHKE1-14/VF/TD_P"_3?X4?:8_23_OTW^%44345#]IC])/^_3?X4?:
M8_23_OTW^% $U9VNV<M_HMS;PC,K %1GJ00<5;^TQ^DG_?IO\*/M,?I)_P!^
MF_PJ914DXOJ*45)-,\Z;PSK/FB+[$[8&<AAM_/-3VNLC3_#+VEM,\-^;@D[5
MZ+WY_"N_%S&#TD_[]-_A7,W'A/3IKLRQSW4<;'+1^4QY/7!Q7GRPDJ>M(X)8
M:4-:1OZ3<-=Z1:3N^]WC!9O4]ZN5PF@ZZNB/-I]X)&C\[ 8=(^H)QU]#BNQ@
MU&UNHA+;R&6,G 9$8C^5=5"JIQ7?J=-&JIQ7<M450GUK3;241W-TL+D9VNK
MX]>E<QIWB>9_$C^=*[6<[F-$SPG/RD?Y[U4Z\(-)]2IUHP:3ZG;45#]IC])/
M^_3?X4?:8_23_OTW^%;&I-140N(ST$G_ 'Z;_"J-UX@TRRF\JXN"DG=?+;*^
MYXXJ9245>3L*4E%7;-.BN;3Q0)?$BV,:HUH?E\P*2Q;&>/;/'2M[[3'Z2?\
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MZ+N314/VF/TD_P"_3?X4?:8_23_OTW^%>@=Q-14/VF/TD_[]-_A1]IC])/\
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M.-3P8^GS#'?@_G7::M<R6>D7=Q$ 7CC)&:Y?1?#4&HZ/:W$KE7,S._R9WKG
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MGHH KV]E;VKN\*;6?KEB?? ST')X%8VD$_V/9\_\LEKH:Y[2/^0/9_\ 7):
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?\: +-%5O[1L?^?ZU_[_ "_XT?VC8_\ /]:_]_E_QH LT56_M&Q_Y_K7_O\
M+_C1_:-C_P _UK_W^7_&@"S15;^T;'_G^M?^_P O^-']HV/_ #_6O_?Y?\:
M+-%5O[1L?^?ZU_[_ "_XT?VC8_\ /]:_]_E_QH LT56_M&Q_Y_K7_O\ +_C1
M_:-C_P _UK_W^7_&@"S15;^T;'_G^M?^_P O^-']HV/_ #_6O_?Y?\: +-%5
MO[1L?^?ZU_[_ "_XT?VC8_\ /]:_]_E_QH LT56_M&Q_Y_K7_O\ +_C1_:-C
M_P _UK_W^7_&@"S15;^T;'_G^M?^_P O^-']HV/_ #_6O_?Y?\: +-%5O[1L
M?^?ZU_[_ "_XT?VC8_\ /]:_]_E_QH LT56_M&Q_Y_K7_O\ +_C1_:-C_P _
MUK_W^7_&@"S15;^T;'_G^M?^_P O^-']HV/_ #_6O_?Y?\: +-%5O[1L?^?Z
MU_[_ "_XT?VC8_\ /]:_]_E_QH LT56_M&Q_Y_K7_O\ +_C1_:-C_P _UK_W
M^7_&@"S15;^T;'_G^M?^_P O^-']HV/_ #_6O_?Y?\: +-%5O[1L?^?ZU_[_
M "_XT?VC8_\ /]:_]_E_QH LT0?\A2#_ *Y2?S2JW]HV/_/]:_\ ?Y?\:DLK
MJWN-5A$%Q#*1%(2(W#8Y3TH VJ*** "BBB@ HHHH Y[4[>[TJ-;C3&61@'3R
MIY54 ;&V*I.. V.,]._%6M(1O,FC,J3VZ*FPL8RP8YW#Y  %Z =\@]L58U>+
M3I+!I-3B22WA82?,F[:P/! '.>W'7..]1:+)%(EQY>G_ &,B0@#[.T6],G:>
M0,G'Y4 8\DNI?:+A9);>.6%7\ATDAQ*QD;"N#R%"[,@8/!Y)Q6MK3WEK:136
M26[2*S;TD95#_(V "?\ ;VGJ. :I7C:'9ZI+']FT]+F21);@W&U<JP(+KGJ?
ME[5IZREA)88U&W,]N&#8$1?:1R&X&1C'6@"KHRR>9(C2QS0"-",F,LKG)8#9
MP%' Y[Y[5G7$NH&ZG222"(P"5H)$DA^=BYV*P;D )MSTZ'DUI:#>6=V;O[+;
M0P;),#RXMFY/X2>!SUXK/O[K0K74KI4L89;S?&]R&M7;<#D$J=I!; [=>* -
MB_6==-#1-#',"A=^ ,9&X*6X!(R!FLSP_)>3S@W(108V::)GA;]YD8,?EYPO
M7.XD\CWK:O(;2\TV6.]A1K1X\R)*O 7&>1VQ^E9^BSVDUU-]ET[R(=BF&;[*
MT?F(0,Y)4=^W?K0!0U62^BU3R]P-L7W#R'@1X@%&W_6>IW9Z\%<8YSJ2+=?V
M%&YDMUN]B&25,!3R-VTGC)&<9XSBJFLG2+2^:66ULCJ$\65:YPJR*I Y8\9
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M6QT.<\4 8VH?VB]^VR[2W>*20KAX/*9<'8,,"X;.W=T&-V.U;NH>?'I7F0B
M3C9O(( QD;MI;C.,XSQG&:R-2N-$L;Z5CIT;74TJ&<RVS89<X9P=N"<=QUQ6
MWJ8L7TB?[?$LEEY>9$*%LK]!S^5 &1H27GVV3S;I)K=][^7*T32)RNW_ %8
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M#JK()(XV8;3C(; ( ) Z]Q5?PW]FFL)KF&+RWN)=TT8+%58*%PN>@P!P..M
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MKH5Q%*\ \X; LY&UO4#/&<9QGC.*GCT33HIUE2WP5?>J;V**WJ$SM!]P*T*
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EBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  V :T# 2(  A$! Q$!_\0
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MC(S28(I0>)K.2]AM9XY;.2:,R1_:=J;L,%P.>2<@C'6M-+VUD:8)<PL8?]:
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M?6+[3M3OY5EDFLYIY6.+1V/RVZ,'7GH3D8Z>^:-M \S3M_ \%N\3&Z$I2U2
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MY8'[E?X9S-_,X^E9:^)-<NM.4W0A@BN6,4C1PNSVS;'.QEP.I"@'GJ?45?\
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/ **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 04, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000831001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Citigroup Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-270327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Nov. 04, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 55.24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 04, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">55.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">55.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp236919_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp236919_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp236919_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp236919_exfilingfees.htm">dp236919_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/ffd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp236919_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp236919_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/ffd/2024": 3,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024": 31,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236919_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236919_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236919_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236919_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236919_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236919_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0000950103-25-014291-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-014291-xbrl.zip
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M&1)\\PVVCN=Z*#OD!\JR_)#?+M?^!U!+ 0(4 Q0    (  6+9%LIUD7T3 L
M (!!   9              "  0    !D<#(S-CDQ.5]E>&9I;&EN9V9E97,N
9:'1M4$L%!@     !  $ 1P   (,+      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>dp236919_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="ixv-211">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="ixv-212">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="ixv-213">0000831001</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="ixv-214">333-270327</ffd:RegnFileNb>
    <ffd:FormTp contextRef="c_report" id="ixv-248">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="ixv-249">Citigroup Inc</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="ixv-250">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="ixv-251">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="ixv-253">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="ixv-254"
      unitRef="shares">400</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-255"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-256"
      unitRef="USD">400000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-257"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-258"
      unitRef="USD">55.24</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="ixv-259">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="ixv-260">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="ixv-262">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_2"
      decimals="0"
      id="ixv-263"
      unitRef="shares">0</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-264"
      unitRef="USD">0.00</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-265"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-266"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-267"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-268"
      unitRef="USD">400000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-269"
      unitRef="USD">55.24</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-270"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-271"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-272"
      unitRef="USD">55.24</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-275"
      unitRef="USD">400000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-276">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
